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1 Aims of the thesis  
This research work has been carried out in a tissue engineering context 
where the microfabrication system, developed and optimized in our 
laboratories and able to fabricate scaffolding supports of controlled 
geometry represents the core. 
Our microfabrication technique makes use of polymeric solutions that are 
extruded over a platform moving on motorized slides along three mutually 
independent orthogonal directions and following a specific and 
predetermined trajectory chosen by the operator. LabVIEW software 
controls and moves the slides, thus allowing the deposition of the extruded 
polymer solution filament forming the desired geometry scaffold. 
The system is innovative among all the tissue engineering solid free form 
(SFF) fabrication techniques already developed and studied, because it can 
fabricate reproducible three dimensional (3D) scaffolds with a well defined 
geometry and porosity at micro-scale level. This has been achieved by using 
3 slides having a resolution up to 1 µm and an extrusion syringe needle with 
inner diameter of 60 µm. 
Main processing parameters are polymer viscosity, slide velocity, and 
solution flow rate, and these, together with the environment conditions, 
greatly affect the fabrication process. 
Using both synthetic and natural polymers microfabrication of different 
scaffold materials was performed. 
Materials were characterized before and after scaffold fabrication to assess 
if any modification occurred; general processing parameters were defined 
according to the material utilized. 
Aims of the thesis 
 
12 
 
Furthermore, preliminary in vitro cell culture studies were performed on the 
microfabricated scaffolds and the relationship between cell types and the 
microstructure was then considered. In particular, cells attachment, 
proliferation, and migration inside the microporous matrix were evaluated. 
The study was mainly conducted at the Department of Materials 
Engineering, University of Trento (Italy). Part of this activity was made in 
collaboration with Tugba Endogan, a PhD student from the METU - 
BIOMAT, Department of Polymer Science and Technology, Ankara 
(Turkey), who spent six months in our lab. 
 
In addition to the above activity, during a six months stage with the Prof. 
Dietmar W. Hutmacher at the Queensland University of Technology, 
Brisbane (Australia), a different microfabrication technique was studied. 
Scaffolds made by Fused Deposition Modeling (FDM), were cell cultured 
over different time points with human osteoblasts. Cells attachment, 
growing and proliferation were measured by imaging analysis techniques 
and specific proliferation assays, respectively. Cell culture was performed 
by adding to the culture medium supplements; calcium phosphate synthesis 
and the formation of detachable osteoblast sheets were induced. 
 
In general, the work aimed at investigating how the two techniques, able to 
produce tissue engineering scaffolds with ordered structure, could assist the 
cellular growth and tissue regeneration.  
 
This thesis has been structured with an introduction where the state of the 
art of tissue engineering has been reviewed. In particular the relationship 
Aims of the thesis 
 
13 
 
between different scaffold structures and morphologies and tissue types has 
been considered. 
After the introduction part, the core section is divided as: 
• PART 1: Scaffold production by microfabrication 
o Microfabrication of synthetic polymers (PDLA, PLGA) 
o Microfabrication of natural polymer (Chitosan) 
o Microfabricaiton of chitosan filled with ACP particles 
• PART 2: Fused deposition modelling scaffold for human osteoblasts 
cell culture 
Background 
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2 Background 
2.1 Tissue engineering 
 
Tissue engineering refers to a field of therapeutic or diagnostic products and 
processes which are based upon the combination of living cells, engineering 
biomaterials and suitable biochemical factors, to restore, improve or 
maintain biological functions. 
Tissue engineering can be defined as an interdisciplinary field combining 
bioengineering, life science and clinical sciences1. 
MacArthur and Oreffo considered tissue engineering as "understanding the 
principles of tissue growth, and applying this to produce functional 
replacement tissue for clinical use"2. Further descriptions focus on the 
principle that the employment of natural biology of the system will allow 
for greater success in developing therapeutic strategies aimed at the 
replacement, repair, maintenance, and/or enhancement of tissue function. 
In other words tissue engineering applies principles and methods of 
engineering and the life sciences to make clear the relationship between 
structure and function in normal and pathological mammalian tissues to 
finally develop biological substitutes to restore, maintain or improve 
function3. 
Actually tissue engineering covers a broader range of applications and it is 
closely connected with other fields, i.e. cell transplantation that is 
transplantation of cells that perform a specific biochemical function (e.g., an 
artificial pancreas, or an artificial liver). 
Background 
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The term regenerative medicine is often used synonymously with tissue 
engineering, although those involved in regenerative medicine place more 
emphasis on the use of stem cells to produce tissues4. 
Generally, tissue engineering revolves around the use of living cell and/or 
extracellular matrix (ECM) components in the development of implantable 
parts or devices and in particular one of the main target of tissue engineering 
concerns cell seeding on porous biodegradable 3-dimensional scaffolds, 
following by implantation of the scaffold into the injured area to provide 
regeneration. 
2.2 Tissue engineering products 
 
Based on the concept that each tissue is characterized by different functions 
and features the tissue-engineering products design strongly depends on 
material properties and on cellular response to the chosen biomaterials. In 
addition, the ability to shape into the suitable cellular level architecture has 
to be taken into account and the final architecture must be compatible with 
the desired tissue response. 
The proper biomaterial selection is assisted by the development of methods 
and sophisticated modelling techniques that permit prediction of polymer 
properties and cellular response to the material. Such techniques allow a 
wide use of biodegradable polymers for tissue engineering applications. 
Tissue engineering products can be designed to conduct, induct or block 
tissues responses and architectures. Depending on the final purpose barriers 
(membranes or tubes), gels or matrices can be developed5. 
Membranes are required where cell activity is needed on one surface of a 
device precluding transverse movement of surrounding cells onto that 
surface. For instance peripheral nerve regeneration needs an axonal growth 
Background 
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and at the same time preventing fibroblast activity that would produce 
neural-inhibiting connective tissue6. Furthermore, collagen membranes used 
in periodontal repairing provide the right environment for periodontal 
ligament regrowth and attachment but at the same time they avoid the 
ephitelial ingrowth into the healing site7. Prevention of post-surgical 
adhesion obtained by using hyaluronic acid compounds is another example 
of barrier biomaterials. 
Hydrogel biomaterials can encapsulate and represent a specialized 
environment for isolated cells. Collagen gels, for instance, can be used for 
the preservation and immunoprotection of xenograft and homograft cells, 
such as hepatocytes, chodrocytes, and islets of Langerhans, used for 
transplantation. Semipermeable gels can be a support for cells in systems 
where cell-cell communication and interaction with surrounding tissue has 
to be minimized as well as the movement of peptide factors and nutrients 
through the implant. Gels are particularly suitable in applications such as 
bone and cartilage tissue regeneration where the material has to be 
injectable and polymerization in situ is needed8. 
Tissue engineering scaffolds or matrices are an important component for 
tissue development and their characteristics such as pore size and the 
structure, ordered and regular or randomly distributed, are fundamental in 
forming tissues with a proper cell morphology, orientation, arrangement of 
intercellular material, and the relationship between different cell types. 
Besides several techniques have been developed to form well defined 
scaffolds using different kind of biomaterials and physical characteristics of 
the matrices can be varied to maximize cellular and tissue responses5,9,10. 
Background 
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2.3 Scaffolds in tissue engineering 
 
The development of 3D scaffolds, support structures or matrices that induce 
cells to form functional tissues, is one of the main object of tissue 
engineering. 
In particular by using scaffolds, transplanted cells can be delivered to a 
specific place in a tissue driving the growth of cells inside a desired 
anatomic site. Thus scaffolds represent the space available for the tissue to 
develop and a physical support for cells growth. 
Three dimensionally (3D) porous matrices provide mechanical and adhesive 
support for seeded cells in culture and tissue in-growth allowing 
vascularisation and shape maintenance during the tissues regeneration. 
Mechanical support against compressive or tensile forces present inside the 
physiological environmental system of the human body should be granted 
depending on the tissue the scaffold is designed for. 
Enough mechanical strength and stiffness is needed to initially contrast 
wound contraction forces and later to guarantee a perfect reconstruction of 
the tissue. For this reason scaffold degradation profile must be designed so 
that it can support the tissue formation until neotissue (cells and 
extracellular matrix without vascularisation) is developed11. 
Injecting cell suspension without scaffold has been sometime utilized as a 
technique12-14 even if it presents the disadvantage that it is quite complicated 
to control the placement of transplanted cells and most of the mammalian 
cells reveal an anchorage-dependent behaviour and they difficult survive 
without a proper adhesion support. 
Therefore the primary function of a scaffold is tissue conduction and thus it 
must allow cells attachment, migration onto or within the scaffold, cells 
Background 
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proliferation and differentiation. The morphology of the scaffold should be 
designed to be able to guide the formation of the new tissue in terms of pore 
size, shape and vascularisation. 
Scaffold geometry should also define the space and the outer shape of the 
defect or lack to finally be properly adapted, also matching the healthy 
tissue stiffness and strength while maintaining an interconnected pore 
network for cell migration and nutrient transportation. It must also provide 
an environment in which cells can maintain their phenotype and synthesize 
proteins and molecules. 
Compatibly to the structure of the tissue scaffolds should be designed to 
have high porosity, high surface area, fully interconnected geometry, 
structural strength and a specific three dimensional shape. Besides, scaffold 
materials should be biocompatible and biodegradable or resorbable so as to 
allow replacement by newly formed tissue in long term. 
A porous structure is usually needed for two critical functions. First, pore 
channels provide ports of entry for migrating cells or for capillary suction of 
blood. Secondly, a large area is available for specific and numerous cell 
interactions. 
In particular microporosity is fundamental for capillary ingrowth and cell-
matrix interactions while macroporosity for nutrients supply and waste 
removal of cells grown on the scaffold. 
It is important to underline that the ideal scaffold design does not exist but 
each tissue requires a specific matrix design with defined material 
properties. 
Finally scaffolds should be manufactured in a reproducible, controlled and 
cost effective fashion with the possibility to include biological component, 
such as cells and grow factors. 
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The regeneration steps of a tissue are presented schematically as follow: 
- Fabrication of a porous 3D scaffold of a well defined geometry and 
porosity 
- Cell culture of porous scaffold; growth factors can be included 
- Cell growing, proliferation and differentiation and tissue formation 
while scaffold is degrading 
- Culturing and then implanting the scaffold into the defect part 
 
It must be considered however, that for regulatory reasons and intrinsic 
difficulties associated with the above procedure, pre-seeded scaffolds use 
could be limited to specific applications and restricted to a few authorized 
institutions. This could favour the implant of tissue engineering scaffolds 
directly in the body without preseeded cells. 
 
2.4 Polymers in tissue engineering 
 
Various materials have been utilized to produce scaffolds for several 
applications. The most important one are natural and synthetic polymers. 
Ceramic materials are also used, particularly in combination with polymers 
especially in bone tissue applications, thus forming composite materials 
with improved mechanical and biological properties. 
2.4.1 Natural polymers 
 
Naturally-derived polymer materials15,16, such as collagen, fibrin, 
glycosaminoglycans (GAGs), chitosan, alginates and starch, can be 
extracted from plants, animals or human tissues; they exhibit good 
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biocompatibility, low toxicity and a low chronic inflammatory response but 
they can undergo to batch-to-batch variations, they show a short range of 
properties and difficult processing. 
They can be combined into a composite with other natural materials or 
synthetic materials and can be degraded by naturally occurring enzymes. 
Disadvantages include poor mechanical properties and they often require 
chemical modification to increase strength such as cross-linking by 
dehydrative methods or chemical methods (glutaraldeyde). 
2.4.1.1 Collagen 
 
An example of a commonly used natural material is collagen. Collagen is a 
major protein of the extracellular matrix, which is a component of 
connective tissues and can provide mechanical support; therefore it is a 
fibrous protein with a long, stiff, triple-stranded helical structure. There are 
three main collagen types: type I (in skin and bone), type II (cartilage), type 
III (blood vessels walls). 
It is possible to built porous collagen scaffolds by freezing a dilute 
suspension and then inducing sublimation of the ice crystals by exposure to 
a low temperature vacuum. 
Clinical applications of collagen scaffolds are highly relevant to 
otorhinolaryngological practice. These include the manufacture of sutures, 
haemostatic agents (powder, sponge, fleece), blood vessels (extruded 
collagen tubes) tendons and ligaments, dermal regeneration for burn 
treatment and peripheral nerve regeneration (porous collagen-GAG 
copolymer)7,15,17-20. 
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2.4.1.2 Chitosan 
 
Chitosan is the N-deacetylated derivative of chitin, a natural polysaccharide 
commonly located in the exoskeleton of crustaceous and insects21,22. 
It is a linear polysaccharide composed of β (1-4) linked D-glucosamine with 
randomly dispersed N-acetyl-D-glycosamine groups.  
Chitosan can undergo to degradation by enzymes such as chitosanase and 
lysozyme. 
There is a big concern around this natural polymer in tissue engineering 
field because it is a well tolerant implant material, non-antigenic, 
biodegradable and it has good structural properties. Chitosan biodegradation 
rate depends on the amount of residual acetyl content, that is the 
deacetylation degree23. Molecular weight and deacetylation degree affect 
physical and mechanical properties of the polymer24,25. 
Chitosan is insoluble above PH 7 and soluble below PH 5; it can be gelled 
into strong fibers when PH is enough high. Hydrogels can also be produced 
by either ionic bonding or covalent cross-linking, using cross-linking agents 
such as glutaraldehyde. 
Chitosan can be formed into membranes and matrices for tissue engineering 
applications. Biological evaluations by colturing hepatocyte cells on 
chitosan scaffold show how cells maintain their morphology once seeded; 
metabolic activities, such as albumin secretion and urea synthesis, are 
present as well. 
Chitosan material has also been used to produce scaffolds for bone tissue 
regeneration and to support chondrocyte attachment and growth. 
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Figure 2.1. Deacetylation of chitin by NaOH and chitosan formation 
2.4.1.3 Glycosaminoglycan 
 
Glycosaminoglycan (GAGs) are glycoproteins widely present inside the 
ECM of the body; many studies have proved the success of combining GAG  
and collagen to form a nanofibrous scaffolds19,26. 
GAGs are long chain not branched consisting of disaccharide units 
containing carboxylic and/or sulfate ester groups, that are functional groups 
able to bridge and link collagens to finally construct interpenetrating 
networks of extracellular matrix (ECM). 
Hyaluronic acid is a fundamental compound of connective tissues in 
mammals and represents the most common GAG; it is an anionic 
polysaccharide with repeating disaccharide units of N-acetylglucosamine 
and glucoronic acid, with unbranched units ranging from 500 to several 
thousands. 
It has a extremely high water-binding capacity and dilute solutions of 
hyluronic acid show high viscosity values. 
Hyaluronan is naturally found in many tissues of the body, i.e. skin, 
cartilage and the vitreous humor and it is particularly used in biomedical 
applications according to these tissues. It has been used during eye surgery 
since 1976 and later to treat osteoarthritis of the knee27. In addition, in the 
form of gels and films it can be utilized to prevent postsurgical adhesion28. 
 
Deacetylation 
NaOH 
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Recent studies show how hyaluronic acid can be used as scaffold material to 
support chondrocyte growth29; similar applications for bone tissue 
regeneration have also been considered30. 
Hyaluronic acid derives from natural sources, such as rooster combs, or 
from microbial fermentation and it is quite easy to isolate and modify.  
2.4.1.4 Silk Fibroin 
 
Silks are fibrous proteins having interesting properties produced in fiber 
form by silkworms and spiders. Sutures produced by silk fibers material 
have been widely used for centuries. Recently starting from regenerated silk 
solutions a variety of biomaterials, such as gels, sponges and films have 
been produced for medical applications. 
In particular silks from silkworms (e.g., Bombyx mori) have been explored 
to evidence possible usages as biomaterials according to different 
applications31,32; furthermore several processing mechanisms have been 
developed. 
In general silk fibroin materials exhibit a good biocompatibility able to 
support the growth of human cells. 
2.4.1.5 Agarose 
 
Agarose is a polysaccharide polymer extracted from algae and it is widely 
used in various fields of biomedical research, particularly in tissue culture 
systems because it permits cells to growth inside a three-dimensional 
suspension. Its molecular structure is composed by an alternating copolymer 
linkage of 1,4-linked, 3-6 anhydro-α-galactose and 1,3-liked-β-D-galactose 
and due to its high amount of hydroxyl groups it results very soluble in 
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water. A double helix structure is formed by interaction of two agarose 
chains by hydrogen bonds. Agarose material undergoes to enzymatic 
degradation by agaroses and properties of agarose gels, especially strength 
and permeability, depend on concentration of agarose.  
Agarose gels are particularly important in the application of tissue 
engineering concepts as regard to cartilage repair because it supports the 
cartilage phenotype as well as nerve regeneration 33. 
2.4.1.6 Alginate 
 
Alginate is a naturally derived polysaccharide that is abundant in cell walls 
of brown algae. As for agarose it shows a very high solubility in water. It is 
a polyanion composed of two repeating monomer units: β-D-mannuronate 
(M) and α-L-guluronate (G). Physical and mechanical properties of alginate 
are highly related to the guluronate block, in terms of chain length and 
proportions, that is present inside the polymer. 
Alginate has an electrolytic nature and it has the exclusive property of being 
able to form a gel in the presence of certain divalent cations (e.g., calcium, 
strontium, or barium); for the same reason alginate gels can be solubilized 
when cations are removed. 
Alginate has been used for tissue engineering scaffolding and different cell 
types have shown to keep their morphology once in contact with the 
material. 
Alginate sponges have been used for fibroblasts cell culture34 and cell 
adhesion was found to be non dependent on scaffold porosity; besides while 
chondrocytes could proliferate and express type II collagen once embedded 
in alginate matrix. Hepatocytes were also seeded on alginate porous 
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scaffolds where albumin was found to be secreted, a good index of cell 
functionality35. 
2.4.2 Synthetic polymers 
 
Biodegradable polymers which are chemically synthesized are widely used 
as scaffold materials in tissue engineering because they typically offer an 
high versatility, stable properties and good workability36.  
Therefore tailing synthetic polymers is easier compared to natural polymers 
and a wider range of shape and properties can be obtained; furthermore the 
final result is more predictable and the scaffolds are more uniform5. 
Degradation rate of scaffolds can be adapted to the specific applications by 
selecting specific polymers, copolymers or blends. Most of these polymers 
undergo to a simple hydrolytic degradation. 
However, biocompatibility of synthetic polymers is generally lower then 
natural polymers. For acidic degradation products, high local concentrations 
of these products can affect cell growth on the scaffolds in vitro and cause 
inflammatory responses in vivo. 
Among these bioresorbable polymers, the most used as scaffolds are 
poly(glycolic acid) (PGA), poly(lactic acid) (PLA) or their copolymers or 
blends  as well as the aliphatic polyester polycaprolactone (PCL). 
2.4.2.1 Poly(glycolic acid), poly(lactic acid) and copolymers 
 
Poly (α-hydroxyacids) are bioabsorbable synthetic polymers widely known, 
studied and successfully employed as tissue engineering scaffolds for cell 
transplantation and tissue regeneration. The homopolymers poly(glycolic 
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acid) (PGA) and poly (lactic acid) (PLA) and their copolymers (PLGA), are 
all poly (α-hydroxyacids)1,5,37-40. 
 
A B 
 
C 
Figure 2.2. Chemical formula of PLA (A), PGA (B) and copolymer PLGA (C) 
 
These linear aliphatic polyesters degrade by hydrolysis and the degradation 
rate of these polymers depends on configuration structure, initial molecular 
weight, exposed surface area, crystallinity, stresses, amount of residual 
monomer, site of implantation and, in the case of copolymers, the ratio of 
the hydroxy acid monomers. 
The poly (α-hydroxyacids) polymers have a modest range of mechanical 
properties but and being thermoplastics polymers they can easily be shaped 
into films, tubes and matrices using standard processing techniques as 
molding, extrusion, solvent casting and spin casting. Ordered fibers, 
meshes, and open-cell foams have been formed to fulfill the surface area 
and cellular requirements of a variety of tissue-engineering constructs. 
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PGA has the simplest chemical structure, thus it has an high degree of 
cristallinity, high melting point and low solubility in organic solvents. It has 
been widely used as surgical suture materials and since it has a very high 
affinity with water, mechanical strength of the sutures decreases rapidly 
within 4 weeks inside a biological environment. 
As shown above (Figure 2.2 A and B), PLA, presents in its chemical 
structure an extra methyl group, thus resulting more hydrophobic then PGA. 
Since degradation is controlled by the degree of access that water molecules 
have to ester linkages in the polymer chains, PLA degrades at a much 
slower rate compare to PGA. 
PLA is also more soluble in organic solvents than PGA. 
Due to the chiral nature of lactic acid, two stereoisomeric forms are possible 
and distinct polymers can be obtained: the two stereoregular polymer D-
PLA, L-PLA, and the D,L-PLA. Poly-L-lactide (PLLA) is the product 
resulting from the ring-opening polymerization of L-lactide; it presents a 
cristallinity of about 37% with glass transition temperature between 50°C 
and 80°C and fusion temperature between 180°C and 190°C. Poly-D-lactide 
(PDLA) is analogous to PLLA but it is derived from polymerization of D-
lactide; it exists just at an experimental level without practical applications. 
Poly-D,L-lactide (PDLLA) is the racemic polymer obtain from a mixture of 
D- and L-lactic acids; it has an amorphous structure presenting a glass 
transition temperature at about 60°C. 
The degree of crystallinity strongly affects the water uptake and the 
degradation kinetic; consequently, amorphous regions offer a better 
accessibility and mobility to water molecules and, degradation occurs at 
higher rate. The less crystalline racemic mixture D,L-PLA degrades at 
higher rate than L-PLA. Differences in cristallinity also influence the area of 
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applicability field of the polymers and for example amorphous polymers are 
usually more suitable for drug delivery applications where it is easier to 
homogeneously distribute the active species inside the supporting matrix 
while semicristalline materials have better mechanical properties and they 
are chosen in applications where a structural support is needed. 
Especially in bone tissue regeneration the combination of PLA, PGA and 
their copolymers together with ceramic materials such as Bioglass particles 
or hydroxyapatite has been considered. These fillers can induce bone 
regeneration and at the same time improve the mechanical properties of the 
material. Bioglass particles also have been shown an angiogenic character. 
Biocompatibility plays an important role in the long and short term success 
of all implants; for biodegradable devices it is fundamental that both the 
implant and its degradation products are biocompatible and non-toxic. 
These issues have been widely studied for PLA, PGA and copolymers and 
several publications reported in-vitro and in-vivo studies of 
biocompatibility. Some complications have occasionally been reported 
following implantation of PLA-PGA biomaterials and some of these 
problems may be attributable to the release of acidic degradation products 
after material degradation. Nevertheless the majority of clinical studies 
citing complications in human due to PLA and PGA implants report only 
soft reactions and suggest non-specific foreign body reaction as the cause41. 
2.4.2.2 Polydioxanone (PDS) 
 
Polydioxanone derives from a ring-opening polymerization of p-dioxanone. 
The products of its degradation are particularly non toxic in-vivo and it 
possesses a better flexibility if compared to PGA and PLA. PDS 
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degradation rate is comparable to that of PGA and is in general faster than 
PLA. 
Often used combined with others polymers thus forming copolymers, PDS 
is used to produce suture filaments. 
 
Figure 2.3. Chemical formula of PDS 
 
2.4.2.3 Poly(ε-caprolactone) 
 
Poly(ε-caprolactone) is a biodegradable aliphatic polyester with important 
applications in the field of human therapy, due to its biocompatibility and 
bioresorbability. PCL has a low melting point at about 60°C, a glass 
transition temperature at -60°C, thus in a rubbery state at room temperature, 
and in general a quite high thermal stability (decomposition temperature 
occurs at 350°C). It is obtain by a ring-opening polymerization of ε-
caprolactone using a catalyst such as stannous octanoate. 
PCL can be degraded by hydrolytic mechanism and therefore under 
physiological conditions42,43. Enzymatic degradation is also possible under 
certain conditions. In general degradation rate of PCL is slower than PGA 
and PLA thus resulting more suitable for long term implantable devices. 
PCL can be combined with other biomaterials to form blends and ε-
caprolactone can be copolymerized together with other different monomers. 
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Figure 2.4. Chemical formula of PCL 
 
2.4.2.4 Polyurethanes 
 
Polyurethane is a term that comprehend a wide family of thermosetting 
polymers in which the polymer chain contains urethanes bonds. 
Polyurethanes are produced by the reaction between a diisocyanate and a 
polyol; a segmented block copolymer is then obtained and low-glass 
transition temperature segments are combined with hard segments. 
Polyurethanes possess excellent physical properties and good 
biocompatibility that make them a good choice for different biomedical 
applications. 
Polyurethanes were first introduced to the medical device market in the 
earliest ‘50s for foam breast prosthesis and cardiovascular devices. Since 
then, a lot of work and development was done to improve their properties 
and biostability. 
In general polyurethanes are used as biomaterials for different applications 
such as pacemaker, lead insulator, catheters, total artificial heart and heart 
valves. 
To overcome the degradation of polyurethanes, several research groups 
have adopted strategies like varying the material chemistry that is altering 
the type and ratio of monomers; incorporation of additives is also possible. 
In particular biodegradable polyurethanes are made from diisocyanates such 
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as lysine-diisocyanate or hexamethylene diisiocyanate that release non toxic 
degradation products instead of the conventional aromatic diisocyanates. 
Biodegradable polyurethanes have been developed for tissue engineering 
applications such as for myocardial repair and vascular tissues44,45. 
 
Figure 2.5. Chemical formula of polyurethane 
 
2.4.2.5 Poly(ortho Ester) 
 
Poly(ortho Ester) are biodegradable synthetic polymers that have the 
peculiarity to degrade by surface erosion, a mechanism by which the 
material is becoming thinner and thinner rather than breaking into pieces 46. 
This property is quite interesting for drug-delivery applications where the 
release results in general more controlled. 
Degradation of poly(ortho ester) is via hydrolysis and degradation rate 
increases with time because the acidic products work as catalysts for the 
degradation reaction. 
 
Figure 2.6. Chemical formula of poly(ortho ester) 
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2.4.2.6 Poly(anhydrides) 
 
Poly(anhydrides) present a excellent in-vivo biocompatibility and they are 
widely used in drug-delivery applications 47; in particular different types of 
drugs and proteins including insulin, bovine growth factors, angiogenesis 
inhibitors, enzymes and anesthetics have been incorporated inside 
poly(anhydrides) matrices. In particular delivery of chemotherapeutic agents 
has been highly investigated. 
 
Figure 2.7. Chemical formula of poly(anhydrides) 
 
2.5 Degradation of Biodegradable Polymers 
 
Applications of biodegradable polymers in medicine comprise resorbable 
surgical sutures, matrices for the controlled release of drugs, tissue 
engineering scaffolds, resorbable orthopaedic devices such as pins, screws 
and plates. 
The applicability of biomaterials refers to a broad field of interest and 
several possible applications can be possible. 
For this reason the development and the choice of biomaterials requires an 
extensive evaluation, in terms of biocompatibility, mechanical properties 
and degradation behavior in order to determine whether a certain material is 
suitable for a particular application. 
In particular, degradation behavior of biomaterials can follow several 
mechanisms and being controlled by different factors. Understanding the 
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degradation kinetics of biomaterials is necessary to optimize their possible 
usage. 
Most biomedical applications require the usage of biomaterials with specific 
controlled and predictable degradations kinetics; this had led to research on 
the degradation behavior of a variety of biodegradable polymers. 
The term biodegradation refers to a degradation occurring in a biological 
environment and maybe defined as the “gradual breakdown of a material 
mediated by a specific biological activity”48. 
Since biodegradable polymers have a temporary function, degradation 
should occur as a controlled mechanism; degradation kinetics, evolution of 
mechanical properties and evaluation of degradation products has to be 
taken into account. 
Particularly in drug delivery applications, the polymer is required to degrade 
following a well defined mass loss profile in order to release the 
encapsulated drugs at specific times. 
The degradation of a polymer can occur at different stages depending on its 
preparation, processing and storage. 
In fact during polymer processing and fabrication some degradation can 
occur affecting also the degradation behavior in vivo. If processing 
techniques involve high temperature or high shear stresses inside the 
material, this may cause degradation of the starting polymer; on the 
contrary, some chain orientation caused by some process could alter the 
degradation time of the polymer, being the material generally more 
resistant. Sterilization method may also have an effect on the material 
degradation causing crosslinking or polymer chain breakage depending on 
sterilization system and the polymer properties. 
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Regarding the degradation mechanisms occurring to materials when 
exposed to the body fluids the most important ones are oxidation and 
hydrolysis. 
A biomaterial can degrade by chemical and enzymatic oxidation once in 
contact with the physiological environment48-50. During inflammatory 
response to foreign materials, inflammatory cells produce highly reactive 
oxygen species, such as suoperoxide (O2-), hydrogen peroxidase (H2O2), 
nitric oxide (NO) and hypochlorous acid (HOCl), which can cause polymer 
chain scission leading to degradation. 
On the other hand hydrolitic degradation is the scission of chemical bonds 
in the polymer backbone by the attack of water to form oligomers and 
monomers. Water attach is directed to water-labile bonds by either direct 
access to the polymer surface or by imbibitions into the polymer matrix 
followed by bond hydrolysis. 
The hydrophilic or hydrophobic nature of polymeric materials influences 
their degradation rate, which is the chemical structure of the polymer: 
covalent bonds in the backbone and no hydrolysable groups require longer 
times to degrade. 
Enzymes known as hydrolases, such as proteases, esterases, glycosidases 
and phosphatases, may catalyze hydrolysis reactions. 
 
2.6 Process techniques 
 
Traditional scaffold fabrication techniques have involved the production of 
porous polymeric matrices as substrate for cell support, adhesion, growth 
and subsequently proliferation and differentiation on or within their 
structure. 
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A big variety of matrices has been developed due to the large range of 
tissues to reproduce and the need to create cellular supports with different 
physical appearance, porosity, permeability, mechanical characteristics. The 
final purpose is to reproduce a micro- and a macro-environment that mimic 
the natural ECM features. Together with the development of advanced 
materials and process engineering 3D matrix formation and fabrication 
techniques have evolved considerably. 
A wide variety of techniques commonly used in tissue engineering generate 
scaffolds with non-ordered structure with unpredictable pore sizes and 
reduced pore interconnections. Any variation in porosity within the 3D 
structure cannot be controlled, and mechanical strength, structural stability 
and reproducibility are generally low. Among these techniques solvent 
casting, freeze drying, phase inversion, fiber bonding, melt based 
technologies, high pressure based methods are the most used. Recently also 
electrospinning technique has widely investigated to produce meshes of 
nanometric fibres for different tissue engineering applications (Figure 2.8). 
To overcome the limits of these methods, more efficient technology to 
generate complex scaffold structures of desired features and solid free-form 
fabrication (SFF) or rapid prototyping (RP) techniques have been 
developed. These computer controlled techniques can generate 
biodegradable polymer scaffolds with designed architecture and shape 
complexity9. 
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Figure 2.8. Poly Amide 6 electrospun meshes51  
 
Figure 2.9. Silk fibroin and PEG sponge (8 % fibroin, 10%w_PEG/w_fibroin) produced by 
salt leaching using NaCl (500 – 1180 nm granulometry)52 
 
Figure 2.10. PCL scaffold obtain by solvent casting/phase inversion in ethanol/water 
solution53 
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Unlike the more traditional techniques, which involve constant removal of 
materials, SFF fabricates scaffolds by selectively adding materials, layer by 
layer, as specified by a computer software. 
High resolution and reproducibility of the scaffold is gained by SFF 
techniques. Fused deposition modelling (FDM), three dimensional printing 
(3-DP), selective laser sintering (SLS) and stereolitography (SLA) are some 
example of rapid prototyping technique. 
Novel robotic assembly and automated 3D cell encapsulation techniques 
have been also improved to have the possibility to add cells during the 
scaffold fabrication 54,55. 
As a result of these technologies, tissue-engineering constructs can be 
contain a controlled spatial distribution of cells, bioactive molecules and 
structural matrices. The combination of these components create a scaffold 
that promote repair and regeneration of the damaged and diseased tissue. 
2.7 Solid Free Form fabrication techniques 
2.7.1 Stereolithography (SLA) 
 
Maybe the precursor among all the RP techniques, SLA system makes use 
of a UV laser beam to polymerize selectively a photopolymerisable liquid 
polymer material. The polymer solidifies from the bath once in contact with 
the beam, at, and just below the surface of the bath. The solidification 
process takes place repeatedly layer over layer. Once the model is 
concluded the extra-resin is washed away and the product is cured in a UV 
oven and finished by smoothing the surface irregularities.  
Nowadays SLA is used mainly to produce anatomical models for surgical 
planning and teaching.  
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The process, due to curing and shrinkage after post-processing, has a low 
resolution and, especially in small and intricate objects, deformation 
phenomena can occur56,57. 
Furthermore only a small amount of biocompatible polymers can 
photopolymerise so being suitable to become a tissue engineering scaffold. 
Polyethylene glycol (PEG) acrylate, PEG methacrylate, polyvinyl alcohol 
(PVA), hyaluronic acid and dextran methacrylate are the most common. 
Micrometric strereolithography can fabricate scaffolds with micrometric 
resolution. 
2.7.2 Selective laser sintering (SLS) 
 
This technique applies the use of a CO2 laser beam able to sinter thin layers 
of powdered polymeric materials. The beam can increase the local 
temperature of the polymer and particles can fuse to each other. The laser 
scans over the powder following the cross-sectional profiles taking by the 
slice data and subsequent layers are formed over the previous one 
introducing extra powder as the preceding layer is completed. 
Simple and linear bulk components can be easily fabricated by SLS 
technique while sheet-like structures undergo to shrinkage. 
Ultra high molecular weight polyethylene (UHMWPE) has been used to 
produce implants by SLS technique and it has been notice that degradation 
(breakage of molecular chains), oxidation and cross linking occurs during 
sintering if the starting polymer molecular weight is not high enough58. 
Furthermore, calcium phosphate (CaP) material was used in combination 
with SLS technique to produce bone implants59. 
Background 
 
39 
 
2.7.3  3D Printing (3DP) 
 
During 3DP process a first layer of polymeric powder is spread over a 
deposition base while a inkjet print head deposits the binder solution over it; 
following, a new layer of powder is spread again on the previous one and 
the printing cycle continues; layers merge together when fresh binder is 
added. At the end of the process the not bonded extra powder is 
removed60,61. 
The technique has been widely investigated in respect of tissue engineering 
applications and drug-delivery systems and the major advantage related to 
3DP is the possibility to work inside an ambient environment. 
Removing the extra powder from complicated shaped model is difficult so 
the technique is suitable for easier geometry without internal holes. 
The printer resolution depends on nozzle size and on the degree of control 
allowed over the position controller that regulates the print head movement. 
The layer thickness is determined by powder size and in general surface 
roughness and aggregation properties of the powdered materials affect the 
final resolution. 
Natural biopolymers have been used in combination with water as a binder 
eliminating the problem to use organic solvents 62. Further post processing 
step to waterproof the product is obviously necessary. 
2.7.4 Shape deposition manufacturing (SDM) 
 
SDM technique makes use of clinical imaging data to control the fabrication 
of layered scaffolds by a computer-numerically-controlled cutting machine 
63
. Addition of cells and growth factors during the three dimensional 
scaffold production is provided as well. 
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The technique was initially though for bone tissue regeneration and 
represents one of the most interesting techniques among all the assembly 
technology-based systems. Osteogenic scaffolds produced by SDM based 
on blends of polycaprolactone (PCL) and poly-D,L-lactide-co-glycolide 
(PGLA) together with HA grains have been reported 64. During the 
manufacturing process, the scaffolds were incrementally built up from thin, 
prefabricated cross-sectional layers of foams made by solvent-casting and 
salt-leaching process. 
2.7.5 Robotic microassembly 
 
The robotic microassembly technique has been studied and developed at the 
National University of Singapore 65. The principle which regulates the 
robotic microassembly technique is that the final scaffold structure is 
composed by small building block units having a different design and 
previously fabricated via lithography or other microfabrication techniques. 
The blocks are then assembled by using a specific precision robotic system 
having microgripping capabilities. Finally a scaffolds having the desired 
material, chemical and physical properties is obtained. 
2.7.6 Microfabrication 
 
The technique aims to produce scaffolds for tissue engineering applications 
having a micrometric resolution. 
Starting from polymer solutions, the extrusion over a platform moving in 
the three main directions is operated by a micro-syringe. 
Well ordered scaffolds can be produced following process parameters set 
through a computer platform and different biomaterials can be used. 
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Figure 2.11. Microfabrication system working principle 
 
2.7.7 Fused deposition modelling (FDM) 
 
FDM is a heat-based manufacturing technology that has been applied 
toward the building of 3D scaffolds 66,67. 
The system includes a head-heated liquefier fixed to a carriage moving 
along the horizontal plane; the head can extrude the material pumping a 
filament of it through a nozzle directly on a platform following a previously 
programmed trajectory. 
Such scaffolds are built up layer over layer in the vertical direction and the 
layer thickness depends on the nozzle inner diameter. 
The technique is limited to thermoplastic polymers with proper viscous 
properties and cells cannot be included during the process. 
Hutmacher and coworkers have used FDM to fabricate bioresorbable 
scaffolds of PCL also in combination with HA and TCP particles thus 
forming composite materials for bone tissue applications. 
A variation of FDM is the so-called precision extruding deposition (PED) 
system which doesn’t need the previous filament preparation but the 
material can be directly extruded. 
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Figure 2.12. Scaffolds of mPCL:TCP (80:20) with a lay-down pattern 0/60/120° (adapted 
from D.W. Hutmacher et al.) 
 
 
Figure 2.13. FDM scheme68 
 
2.8 Porous size and morphology for tissue 
regeneration 
 
Three dimensional porous polymer scaffolds posses a high specific surface 
area for cell anchorage and a big volume fraction for cells growth, 
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migration, and effective fluid phase transport of nutrients. In addition to the 
size of the pores, the morphology can significantly resolve the performance 
of an implanted matrix, including the rate of tissue ingrowth.  
Biological activity of a scaffold is theoretically affected by ligands density, 
i.e. scaffolds site at which specific cell binding occurs. 
Scaffold composition and porous fraction, that is the total surface of the 
structure exposed to cells, determine the ligand density. 
Several research works have demonstrated that pores need to be large 
enough to favour cellular migration into the structure, where they eventually 
bound to ligands expressed on the scaffold surface; furthermore, good 
vascular induction and easy diffusion of waste products is favoured; but 
conversely, pores should be small enough to reach a sufficiently high 
specific surface for a maximal ligand density in order to have an efficient 
binding of a critical number of cells. 
The optimum porosity is strictly connected to the tissue type and diverse 
nature tissue architectures can be associated to a different microenvironment 
to reproduce. Cell dimension, together with cell activity behaviour, 
phenotypic expression and ECM production has also to be taken into 
account when designing a scaffold for tissue regeneration. 
In bone tissue regeneration, for instance, the minimum pore size required is 
considered to be about 100 µm due to cell size, migration conditions and 
transport. However, pore sizes bigger than 300 µm are recommended, to 
improve new bone formation and to develop a net of capillaries 69. 
The investigation over two model cell types, fibroblast and endothelial cells, 
in respect of a range of defined pore features from 5 to 90 µm in scaffolds 
fabricated by photolithographic technique, demonstrates how fibroblasts, 
using a bridging mechanism, can spread over neighbour cells being able to 
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fill even large pores while endothelial cells cannot use this bridging system 
and they prefer pore size close to their dimensions 70. 
In PLLA scaffolds, vascular smooth muscle specifically bind to one range 
of pore sizes (63 – 150 µm) while fibroblast, for their ability to form bridge 
connections, to a wider range (38 - 150 µm) 70,71. 
MC3T3-E1 mouse clonal osteogenic cells cultures on four different 
scaffolds, with variable specific surface areas, confirm a linear relationship 
between cell attachment and specific surface area. Over the range of pore 
sizes studied (95.9 – 150.5 µm) short-term cell viability was determined by 
the specific surface area available for binding 18. 
The rate of degradation is also strictly connected to the degree of porosity. 
For instance in polyester scaffold materials, a high porosity can reduce the 
accumulation of acidic degradation products thus reducing any possible 
reaction. 
Moreover, scaffold heterogeneity has been shown to produce variability in 
cell adhesion and uniform distribution of extracellular matrix proteins is not 
easily obtained 71. Tissues produced from a non-uniform pore architecture 
also show inferior biomechanical properties if compared with tissues 
derived from scaffold having a uniform pore structures 72. Generally cells 
tend to follow the scaffold geometry: if pores are equiaxed, they distribute 
forming a spherical structure while in the case of elongated pores they also 
align along the pore main axis73. 
 
Figure 2.14, Figure 2.15, Figure 2.16 and Figure 2.17 show some examples 
of different scaffolding structures cultured in vitro with different cell types. 
In particular, Figure 2.14 shows human osteoblast cell culture on 
microfabricated chitosan scaffolds after 16 days of cell seeding. The 
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micrometric pore structure revealed to be suitable in term of size for 
osteoblasts growing: cells were able to easily migrate inside the structure 
and pores were quickly filled. The same cell culture was performed on FDM 
scaffolds (mPCL:TCP, 80:20) (Figure 2.15); after 16 days of cell culture 
cells started to form bridge connections at the corners of the structure.  
Figure 2.16 and Figure 2.17 show prostate cancer cell culture (PC3K3s5, 
Kallikrein3 overexpressed modified serine amino acid; derived from bone 
metastatic site) after 21 days on 2-5% PLLA-PDLLA in HFIF electrospun 
mesh and mPCL:TCP (80:20) FDM scaffold, respectively. 
Prostate cancer cells show a round shaped morphology. The electrospun 
mesh works as a barrier for cells while FDM scaffolds pores are definitely 
big compare to cells dimensions. 
  
Figure 2.14. Microfabricated chitosan scaffold seeded by human osteoblasts after 16 days 
of cells culture. A) SEM imaging B) confocal laser microscopy imaging after Phalloidin-
Rhodamine/Dapi staining 
A B 
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Figure 2.15. FDM (mPCL:TCP, 80:20) scaffold seeded by human osteoblasts after 16 days 
of cells culture A) SEM imaging B) confocal laser microscopy imaging after Phalloidin-
Rhodamine/Dapi staining (chapter 5.4.2) 
 
   
Figure 2.16. Electrospun mesh (2-5% PLLA-PDLLA in HFIF) seeded with prostate cancer 
cells (PC3K3s5, PSA overexpressed) after 21 days of cells culture A) SEM imaging B) 
confocal laser microscopy imaging after Phalloidin-Rhodamine/Dapi staining (D. W. 
Hutmacher et al., unpublished results) 
A B 
A B 
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Figure 2.17. FDM scaffold (mPCL:TCP, 80:20) seeded with prostate cancer cells 
(PC3K3s5, PSA overexpressed) after 21 days of cells culture. Confocal laser microscopy 
imaging after Phalloidin-Rhodamine/Dapi staining  (D.W.Hutmacher et al., unpublished 
results) 
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4 Part 1: scaffold production by 
microfabrication 
4.1 Abstract 
Rapid prototyping techniques (RP) hold great promise for designing 3-
dimensional (3-D) regular and ordered scaffolds. With these techniques, 
good architecture reproducibility as well as porosity control of the structure 
can be obtained. 
This work dealt with the fabrication of tissue engineering scaffolds with 
regular micrometric geometry by using an in-house built microfabrication 
system.  
Poly(D,L-lactic acid) (PDLA), poly(D,L-lactic-co-glycolic acid) (PLGA) 
and chitosan scaffolds presenting homogeneously distributed 100 µm size 
pores have been fabricated. Fabrication consisted in a layer by layer 
deposition of filaments of PDLA and PLGA dichloro 
methane/dimethylformamide (DMC/DMF) solutions and chitosan acetic 
acid solutions, respectively, on a plate moving with micrometric precision in 
the x,y,z directions. 
Additional chitosan scaffolds filled with amorphous calcium phosphate 
(ACP) particles were also microfabricated, considering the possibility to 
take advantage of the osteoconductive character of ACP for bone tissue 
regeneration applications. 
The in-house built system utilizes highly accurate 3-D micro-positioning 
slides having a resolution up to 1 µm. Through a microsyringe equipped 
with a micro-needle having 60 µm inner diameter, an automatic pumping 
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system extrudes a filament of the selected solution on a plate. The plate is 
connected to three slides moving independently in the x,y,z directions. A 
computer controls the slides movement so that the filament that deposits on 
the plate builds layer by layer scaffolds of designed geometry. 
Rheological tests have been used to characterize the polymer solution 
viscosities while thermal analysis (DSC), ATR-FTIR and dynamic 
mechanical tests (DMTA) have characterized the produced scaffold. Cast 
films from the same polymer solutions were used as control. Preliminary 
biological evaluations were done by seeding on the scaffolds osteoblasts 
(MG63) and fibroblasts (MRC5) cell lines.  
SEM and LV-SEM imaging evidenced scaffold morphology and cell 
adhesion and growth behavior. 
In addition, surface topography of ACP filled chitosan scaffolds has been 
determined by atomic force microscopy (AFM) and their surface elemental 
composition evaluated by energy dispersive spectroscopy (EDS). 
4.2 Introduction 
Tissue engineering is a challenging field that aims at restoring or replacing 
deteriorating or aging biological structures such as tissues or organs. It 
involves the use of living cells and extracellular components, either natural 
or synthetic, to develop implantable parts1. In particular tissue engineering 
uses a combination of living cells and a porous support structure called 
scaffold on/in which cell attach, grow and proliferate2,3. 
Since tissue engineering scaffold will be implanted in the human body, the 
scaffold materials should meet specific characteristics; in particular the used 
material should be non-antigenic, non-carcinogenic, non-toxic, and possess 
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high cell/tissue biocompatibility so that they will not give rise to any 
unfavourable cellular/tissue reactions after implantation. Moreover, the 
scaffold should have an interconnected porosity with pores large enough to 
permit cell penetration and, at the same time, vascularisation, nutrients 
transport and removal of metabolic waste. However, pore size should not be 
too large, in order to offer to cells a structural support for extracellular 
matrix formation with a morphology resembling the one of the target 
biological tissue. Mechanical properties of the produced scaffold have also 
to be considered in relation to the specific tissue  that the scaffold is thought 
of2-5. 
A wide variety of techniques commonly used in tissue engineering produce 
scaffolds having non-ordered structures with reduced pore interconnections, 
poor mechanical strength and reproducibility; moreover, most of these 
techniques can’t control any variation in porosity within the 3-D structure. 
Among these techniques,  solvent casting, freeze drying, phase inversion, 
fiber bonding, melt based technologies, high pressure based methods are the 
most used. To overcome the limits and the lacks of these methods,  solid 
free-form fabrication (SFF) or rapid prototyping (RP) techniques have been 
introduced in order to computer control architecture and shape of the 
scaffolds6-9. Scaffold with high resolution and reproducibility can be 
fabricated by SFF techniques. Fused deposition modelling (FDM), three 
dimensional printing (3-DP), selective laser sintering (SLS) and 
stereolitography apparatus (SLA) are some examples of rapid prototyping 
techniques7. Some in-house built systems have also been used to fabricate 
ordered and reproducible scaffolds9. 
Microfabrication aims at producing scaffolds of proper 
morphology/geometry with a micro-resolution.  
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Many synthetic and natural polymers, are suitable for the fabrication of 
biodegradable scaffolds. 
 
Members of poly (α-hydroxyl acids) family, such as poly(glycolic acid) 
(PGA), poly(lactic acid) (PLA), and poly(D,L-lactic-co-glycolic acid) 
(PLGA) have been widely used in tissue engineering applications10-13. They 
are considered to be biocompatible with degradation products, lactic acid 
and glycolic acid, that can enter into normal metabolic pathways14,15.  
 
Among natural polymers, chitosan is a well-tolerated, non-antigenic, 
biodegradable16-19. Chitosan is the N-deacetylated derivative of chitin, a 
very abundant natural polysaccharide commonly located in crustaceous and 
insects. The biodegradation time of chitosan is determined by the amount of 
residual acetyl content20-22.  
 
Polymer based composite materials are often used to obtain scaffolds with 
increased properties. In particular, with the use of ceramic fillers, scaffolds 
with better mechanical properties can be obtained. The added value of some 
ceramics is their osteogenic potential, very important for applications for 
bone repair and regeneration. 
 
This work describes the use of a made-in-house microfabrication system to 
produce scaffolds from different materials having a microresolution and a 
well-defined ordered structure. Several physical tests were performed to 
evaluate the starting materials and the produced scaffolds. Preliminary 
biological tests allowed to evaluate cells attachment and penetration.  
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4.3 Materials and Methods 
4.3.1 Microfabrication System 
 
The microfabrication system picture is reported below, Figure 4.1. Three 
independent slides (National Instrument, Austin, Texas, US), computer 
controlled by a labVIEW platform, can independently move in the x,y,z 
directions with a 1 µm resolution. 
  
Figure 4.1: Microfabrication system 
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Figure 4.2. Schematic representation of microfabrication system 
Each slide is connected to a DC motor which can impose a 15 mm/sec 
maximum velocity. The process parameters set by the LabVIEW front 
panels are sent to the axis through a controller which can also receive 
possible limit switch signals back from the slides. 
Figure 4.2 and Figure 4.3 show the schematic representation of the 
microfabrication system and its working principle, respectively 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3. Working principle of microfabrication system 
 
Computer 
LabVIEW software CONTROLLER 
3 Slides  
DC motors 
 
Limit switch signals 
Commands 
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The slides, having a movement range up to 100 mm, move a platform where 
the polymer solution is extruded and the scaffold is built on. The extrusion 
system is composed by a glass syringe fixed up on an automatic pumping 
system (11 Plus, Harvard Apparatus, Massachusetts, US) (Figure 4.4) by 
which it is possible to set the proper flow rate; a metal micro-needle 
(HamiltonTM, 34 gauge – 60 microns inner diameter; 1 cm length, 90º point 
style) is connected to the glass syringe by a luer-lock mechanism. 
 
       
Figure 4.4. A) microfabrication system platform; B) 90° needle point style 
 
 
Since the process strongly depends on environmental variables (such as 
temperature and humidity), a protective glass box encloses the whole 
system, to ensure constant conditions for the deposition. 
 
 
 
The polymer solution is deposited from the needle of the glass syringe with 
a constant flow rate on a polyethylene terephthalate (PET) platform (Figure 
4.5).  
B 
A B 
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Figure 4.5. The micro-needle and scaffold microfabrication 
 
Scaffold is built on layer by layer in the vertical direction. Each layer is 
composed by a series of parallel fibers, deposited by the syringe through a 
back-and-forward movement. The distance between the fibers, which 
influences the properties of the scaffold, is a parameter that the operator 
inserts in the control panel of the software. Once a layer is completed, the 
support moves down by an amount corresponding to the height of the 
deposited fibers, such that the distance between the needle and the 
deposition plane is constant. Then, another layer is deposited, whose fibers 
are perpendicular to those of the previous one, thus resulting in a scaffold 
with interconnected porosity. The number of iterations of this sequence 
determines the number of layers composing the scaffold, while fibers 
dimension depends on the pressure applied to the syringe, the viscosity of 
the solution, the motor speed and the dimensions of the needle.  
 
The process parameters which can be controlled through the LabVIEW 
front panels are the following: slide velocity and acceleration, the distance 
between fibers, the number of layers and the vertical displacement of the 
platform between the depositions of two subsequent layers. Figure 4.6 
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shows the graphical user interface of the labVIEW front panels. 
A 
B 
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Figure 4.6. LabVIEW front panels: A) and B) planar movements, C) vertical movement 
 
Figure 4.7 and Figure 4.8 are the LabVIEW block diagrams associated to 
the graphical user interfaces. In particular, Figure 4.7 shows the block 
diagram that regulates the vertical movement of the platform.  
 
Figure 4.7. LabVIEW block diagram of the vertical movement  
C 
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The program is essentially composed of a “For Loop”, that repeats a number 
of time corresponding to the number of layers the scaffold will be composed 
of. The program uses an incremental number to enumerate the cycles; this 
variable is used to distinguish between odd-numbered and even-numbered 
layers. Depending on that, the program executes alternatively two sub-
programs, which differs on fibers orientation. In that way, odd-numbered 
layers are composed of fibers oriented perpendicularly respect to the ones of 
even-numbered layers. The second part of this block diagram represents the 
vertical displacement, executed after each of the two sub-programs that 
determines in-plane movements. The input values inserted are read by the 
program which actuates the movement. 
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Figure 4.8. LabVIEW block diagram of planar movements 
 
Figure 4.8 is the block diagram related to the planar movement and finally 
associated to the layers formation. It can be divided into two parts: the first 
one represents the creation of an array, that is the instructions for the 
platform to move, forming the grid. Practically, the array corresponds to the 
geometrical parameters of the scaffold. The formed array is then used in the 
second part of this block diagram, where the instructions for the movements 
are taken as input values and used to move the slides. 
 
The needle path to obtain the desired scaffold geometry is described by a set 
of spatial coordinates, which, basically, represent the boundaries of each 
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layer of the scaffold. The back-and-forward movement passing through 
these points determines the fibers deposition. Figure 4.6 shows the graphical 
user interface associated to the subprograms related to the layer formation 
(with two different orientation, A and B in the figure) and to the vertical 
movement (C) of the deposition platform. 
All the process parameters were set from the LabVIEW front panels 
exclusive of flow rate that is controlled directly from the automatic pumping 
system. 
Flow rate, velocity, target position (distance between layers) are strictly 
related to each other and dependent on polymer solution viscosity and 
scaffold geometric features. In the tested solutions the process parameters 
combination related to a specific and pre-determined solution viscosity, 
were fixed as follow: 
• Flow rate:   1 µL/min 
• Slide velocity:   4.6 mm/sec 
• Distance between layer: 25 µm 
Each square scaffold, (generally either 1 cm x 1 cm or 2 cm x 2 cm 
dimensions were chosen), is composed of about 100 µm equidistance rows. 
Synthetic polymer scaffolds were formed by 30 layers while the chitosan 
polymer scaffolds by 80 layers. The final thickness of the synthetic 
scaffolds was approximately 350 µm while natural polymer matrices had a 
total thickness not bigger than 100 µm. 
Part 1: scaffold production by microfabrication 
 
70 
 
Figure 4.9 represents a natural polymer scaffold 2 cm x 2 cm produced by 
microfabrication technique. 
 
 
Figure 4.9. Microfabricated chitosan scaffold 
 
4.3.2 Synthetic polymer materials: PDLA and 
PLGA 
Poly(D,L-lactic acid) (PDLA, type RESOMER® 207, MW= 252 kDa) 
poly(D,L-lactic-co-glycolic acid) (PLGA, type RESOMER® 503, 50:50 
molar ratio D,L-lactide:glycolide, MW= 39 kDa) were purchased from 
Boehringer Ingelheim, Germany. The polymers were used without further 
purification. 
Dichloromethane (DCM) and dimethylformamide (DMF) ware obtained 
from BDH Chemicals (UK) and J.T.Baker (Holland), respectively.  
PDLA and PLGA were dissolved in dichloromethane:dimethyl formamide 
(70:30 v/v) to prepare 20% (w/v) and 25% (w/v) solutions, respectively. 
Before being used inside the microfabrication system, the solutions were 
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magnetically stirred at 40ºC for 18 hours, then filtered with Millipore Nylon 
Net filter having 20 µm pore size. 
The specifications of the solvents are given in the Table 4.1. 
Table 4.1. properties of solvents 
 
Density 
[g/ml] 
Boiling 
Temp 
[°C] 
Viscosity 
[cP] 
Firm Purity 
[%] 
Water 
[%] 
DCM 1.325 40 0.44 BDH (UK) 99.5 0.05 
DMF 0.944 153 0.91 
J.T.Baker 
(Holland) 
99 0.05 
 
Films obtained by casting the solutions in Petri dishes were used as control. 
The solvent was allowed to evaporate gently in order to avoid bubble 
formation. The resulting polymer films were dried under vacuum for 1 day 
at room temperature to produce 0.2 mm thick PDLA and PLGA films. 
4.3.3 Natural polymer material: Chitosan 
Chitosan (low viscosity, 78% deacetylated) and acetic acid were purchased 
from Fluka (Missouri, US). 
Chitosan was used without further purification. Sodium hydroxide (NaOH) 
was obtained from J.T. Baker (Holland). 
Chitosan was dissolved in 5% (v/v) acetic acid to prepare 3% (w/v) chitosan 
solution. Polymer solution was then filtered through Millipore Nylon Net 
filter with 20 µm pore size. 
After microfabrication, chitosan scaffolds were treated with 1 M NaOH for 
one hour and then washed with distilled water until neutrality. 
The specifications of the solvents are given in the Table 4.2. 
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Table 4.2. Properties of solvent 
 
Density 
[g/ml] 
Boiling 
Temp 
[°C] 
Viscosity 
[cP] 
Firm Purity 
[%] 
Acetic 
Acid 
1.049 118.1 1.22 
Fluka 
(MO, 
US) 
99 
 
 
 
Additional chitosan scaffolds filled with amorphous calcium phosphate 
(ACP) particles were fabricated. A solution was prepared dissolving 2.6% 
(w/v) chitosan and 0.4% (w/v) ACP in 5% (v/v) acetic acid solution. 
The particles were synthesized via sol-gel process, which was previously 
described by Skirtc et al.23. The particles mean diameter was kept as 
2.17±2.07 µm. The precursors Ca(NO3)2.4H2O, Na2HPO4.2H2O and 
Na4P2O7.10H2O used in the synthesis of amorphous calcium phosphate 
(ACP) particles were supplied by Sigma-Aldrich (St. Louis, MO – US). 
Films obtained by casting the solutions in Petri dishes were used as control. 
The solvent was allowed to evaporate gently in order to avoid bubble 
formation. The resulting polymer films were dried under vacuum for 1 day 
at room temperature to produce 0.2 mm thick chitosan films. 
4.3.4 Gel Permeation Chromatography (GPC) 
Weight average molecular weight of the used synthetic polymers used was 
determined by gel permeation chromatography (GPC, Spectra System 
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P1500) by using a Shodex K-804 column (Shodex, Tokyo, Japan) and a KG 
pre-column.  
Chloroform was used as solvent for the polymers and 1 mL/min eluent 
constant flux was applied. 
The Universal Calibration method with polystyrene standards was used to 
obtain a calibration curve. 
4.3.5 NMR 
13C  CP MAS NMR spectroscopy was used to determine the average degree 
of acetylation of chitosan. 
Solid State NMR experiments were carried out on a Bruker Avance 400 WB 
spectrometer, operating at 100.613 MHz for 13C. Samples were packed in 4 
mm diameter zirconia rotors which were spun at 9 kHz under air flow. The 
experiment was performed at 13C SP-MAS, operating conditions were 3.5 
µs for 90° pulse and 5.3 µs for decoupling pulse both at -1.7 dB of power 
level, 10 s for recycle delay. Adamantane was used as external shift scale 
reference.  
4.3.6 Rheological Tests  
For rheological measurements on the solutions, a rotational rheometer 
(Advanced Rheometric Expansion System - ARES – TA Instrument, New 
Castle, DE – US) was used. A cone-plate configuration (50 mm plate 
diameter, 0.04 rad cone angle, 0.050 mm initial gap between cone and plate) 
and a dynamic frequency sweep test mode (strain control, 3% strain, 1 
rad/sec initial frequency, 22°C working temperature) were employed.  
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To prevent solvent evaporation during the experiments, a humidity chamber 
enclosing the cone-plate apparatus and lined with a solvent soaked sponge 
was used. Complex viscosity over frequency range between 1 and 100 
rad/sec was measured and efficiency of humidity chamber was tested by 
sequentially running the rheometric measurements on the same sample. 
4.3.7 Attenuated Total Reflectance-Fourier 
Transform Infrared (ATR-FTIR)  
Infrared spectroscopy analysis (Spectrum One Spectrometer – PerkinElmer, 
Germany) was utilized to evaluate possible material modifications due to 
the process or solvent retention. Films from the same polymer solution were 
used as control. 
All the spectra were analyzed after ATR and baseline correction. 
4.3.8 Differential Scanning Calorimetry (DSC)  
Differential scanning calorimetry (DSC) (DSC 30 Mettler-Toledo, USA) 
was performed on polymers before and after microfabrication to investigate 
possible modifications due to the fabrication procedure. Approximately 5-10 
mg samples were placed in aluminum DSC pans. Every sample underwent 
two heating scans from -20°C to 120°C in the case of PLGA and PDLA; for 
chitosan the first scan was from 0°C to 200°C while the second one from 
0°C to 300°C; heating rate was fixed at 10°Cmin-1 and cooling rate at 
100°Cmin-1 under a nitrogen flux of 10 mLmin-1. 
Evaluations on the obtained graphs were performed by STARe – Thermal 
analysis software. 
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Second order phase transition, that is glass transition temperature (Tg) and 
first order phase transition endothermic and exothermic peaks were 
detected. 
4.3.9 Thermo gravimetric analysis (TGA) 
Mettler TG50 thermogravimetric balance connected to a Mettler TC10A 
processor was used to measure weight loss as a function of temperature of 
chitosan polymer, chitosan polymer filled with ACP particles and ACP 
particles. 
A temperature range between 0°C and 800°C was evaluated under a 
nitrogen flux of 200 ml/min. 
4.3.10 Dynamical mechanical thermal 
analysis (DMTA) 
Dynamic mechanical thermal analysis (DMTA) was performed by DMTA 
Mk II (tensile mode) of Polymer Laboratories Scientific Firm.  
The analysis were conducted by keeping the frequency constant (1 Hz) and 
varying the temperature at a heating rate of 3°C/min from −60°C to 100°C 
in the case of PLGA and PDLA and from −60°C to 200°C in the case of 
chitosan material. 
Cast films 40 µm thick were produced and used as a control. 
Storage modulus (E’) and loss factor (tanδ) were plotted over temperature. 
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4.3.11 Preliminary in vitro culture studies 
Human osteosarcoma derived osteoblasts MG63 and human embrional lung 
origin fibroblast MRC5 cell line were seeded on the produced PDLA, 
PLGA and chitosan, plain and ACP filled, scaffolds 
Cells were incubated at 37ºC in a 5% CO2 atmosphere incubator, and when 
reached the confluence stage they were harvested by trypsinization followed 
by the addition of fresh culture medium to create a cell suspension. 
Minimum essential medium (MEM) supplemented with 10% Fetal Bovine 
Serum (FBS), 1% penicillin, 1% Glutamax, 1% Vitamine, 1% non essential 
amino acids was used for MG63 cell line media; 1% Sodium Piruvate in 
addition to these ingredients was used for MRC5 cell line media. 
All of the scaffold samples were sterilized by immersion in 70% ethanol 
followed by washing with distilled water and were seeded with a cell 
suspension of 5x105 cell/mL concentration in 48 well plates. The density of 
cells was determined by a glass hematocytometer. For each well 0.5 ml of 
cell suspension was added. Medium was changed every 2 days. At chosen 
times, scaffolds were removed, cells were fixed and the morphology of the 
cells was examined by SEM and LV-SEM imaging analysis. 
4.3.12 Atomic Force Microscopy (AFM) 
Topography of ACP filled chitosan scaffolds was evalutated by AFM 
analysis. 
Topography was analyzed by AFM (NT-MDT Solver AFM) in contact 
mode, collecting topography profiles maps with silicon contact tips (conical 
shape, angle < 22 deg., typical curvature 10 nm radius, Kel = 0.01 N/m). 
Measurements were carried out in air at room temperature, by a scanning 
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head of 90 µm2 of 10 x 10 µm scan area; the scan frequency was kept 
between 1.0 Hz and 1.2 Hz. 
4.3.13 Sample imaging 
Morphological observations were performed with optical microscopy, 
scanning electron microscopy (SEM) (Cambrige Stereoscan 200 – operating 
mode: high vacuum, secondary electron SE detector) and Enviromental-
SEM (ESEM TMP FEI – operating mode: low vacuum, gaseous secondary 
electron GSE detector). 
Before imaging, biological samples were fixed by using a glutaraldehyde 
solution (25% glutaraldehyde in cacodylic buffer solution 0.1 M, pH=7.2) to 
preserve the structure of living tissues. Then the samples were dehydrated 
by dipping in a series of aqueous ethanol solutions at increasing 
concentrations. Prior to SEM imaging,  samples were sputter coated (SEM 
Coating Unit PS3, Assing S.p.A., Rome, Italy) with a thin layer of gold in 
argon atmosphere (20 mA at 5x10-7 Pa for 30 sec). 
Energy dispersive spectroscopy (EDS, EDAX – Ametek) was used to 
determine the surface elemental composition of chitosan/ACP composite 
scaffolds before and after NaOH washing treatment.  
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4.4 Results and Discussion: synthetic materials 
4.4.1 Microfabricated scaffold 
Scaffolds of PLGA and PDLA were obtained by the superposition of 25 
sequential orthogonal layers. Their optical and SEM images are reported in 
Figure 4.10.  
 
 
Figure 4.10. Optical (up) and scanning electron (down) microscopy images of a PDLA 
(left) and PLGA (right) scaffold 
Setting the proper combination of process parameters was very important to 
produce homogeneous and regular scaffolds. Wrong setting of the machine 
combined with an improper polymer solution viscosity resulted in defects 
being created in the final scaffold structure. Solution viscosity and solvent 
150 µm 150 µm 
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evaporation rate are the main parameters controlling spinning of the solution 
and filament deposition. 
Low-boiling temperature solvents evaporated too fast, even on the needle 
tip, causing the polymer solution to flow discontinuously and to stuck at the 
tip. Similar results were observed when the solution concentration was too 
high. Non-continuous flow created defects in the scaffold such as big 
droplets; moreover, fibers did not bind each other (Figure 4.11, A and B). 
High boiling temperature solvents, on the contrary, were difficult to remove 
from the material, so that the polymer spread on the collecting platform and 
following layers collapsed one over the others. The same effect was 
observed when the polymer concentration was too low (Figure 4.11, C and 
D). 
                                    
 
Figure 4.11. Optical images of a microfabricated scaffold with defects. A and B, PDLA; C 
and D, PLGA 
150 µm 
200 µm 
150 µm 
A B 
C D 
150 µm 
150 µm 
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Pores size and shape could varied depending on spinning parameters. For 
instance, for PDLA, at higher x,y slide velocity (4.6 mm/sec) pores  were 
square shaped sizing about 100 µm (Figure 4.12 A), while more elongated 
smaller pores (Figure 4.12 B) were obtained at slower slide velocity (4 
mm/sec).  
 
Figure 4.12. PDLA microfabricated scaffold 
 
For PGLA, SEM imaging showed a regular structure with 100 µm thick 
polymer rows and about 130 µm side square holes (Figure 4.10). 
PLGA scaffolds were produced by 25 overlapping layers; morphological 
evaluation by imaging analysis (SEM) showed a regular structure with 100 
µm polymer rows and about 130 µm square holes (Figure 4.10). 
Due to the lower solution viscosity (see chapter 4.3.6), in general the PLGA 
scaffolds were more difficult to process than PLDA and a three-dimensional 
structure was hardly obtained. Attempts made to microfabricate PLGA 
scaffolds starting from more concentrated polymer solutions were not 
successful due to the gelification of the solution in the syringe. 
Proper solution concentration was the most important process parameter to 
set for PLGA scaffolds microfabrication. At low polymer concentration 
(15% w/v), the solution flowed out easily through the needle, however once 
B A 
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it was extruded on the substrate the solvent evaporated too slowly and the 
scaffold spread and collapsed. At 30 % w/v PLGA concentration, the 
unstirred solution behaved as a gel. A 25% (w/v) PLGA solution 
concentration resulted to be the optimal as regards the easiness of the 
process and the quality of the obtained scaffolds. 
 
4.4.2 Rheological test on PDLA and PLGA 
solutions 
Flow behaviour of polymer solutions is an important process parameter to 
consider during microfabrication process. 
For this reason rheological test on the polymer solutions were performed in 
order to evaluate in which viscosity range the solutions were extruded 
during the microfabrication process. 
Characterization of polymer solutions flow behaviour and selection of the 
proper viscosity working range in respect to microfabrication process were 
thus evaluated. 
Both PDLA and PLGA solutions, at the concentration value that resulted to 
be optimal during the microfabrication process, were tested by using a 
rotational rheometer by a dynamic frequency sweep test: in this way 
complex viscosity was measured over a frequency range between 1 and 100 
rad/s.  
According to the Cox-Merz rule24, the complex viscosity as a function of the 
frequency corresponds to the shear viscosity as a function of shear rate. In 
addition, the effect of evaporation phenomena was evaluated by performing 
three measurements on the same sample one after one. 
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Figure 4.13 and Figure 4.14 show the graphs resulting from the rheological 
tests on PDLA and PGLA solutions respectively.  
Table 4.3 reports the viscosity values at fixed frequencies in order to 
evidence the effect of the three following runs for the two polymers. 
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Figure 4.13. Rheological test results for A) Viscosity of 20% PDLA solution in DCM:DMF 
(70:30) solvent, B) Viscosity of 20% PDLA solution in DCM:DMF (70:30) solvent 
obtained by three successive measurements 
A 
B 
1st run 
2nd run 
3rd run 
ω [rad/s]
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Figure 4.14. Rheological test results for A) Viscosity of 25% PLGA solution in DCM:DMF 
(70:30) solvent, B) Viscosity of 25% PLGA solution in DCM:DMF (70:30) solvent 
obtained by three successive measurements 
 
 
 
A 
B 
2nd run 
1st run 
3rd run 
ω [rad/s]
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Table 4.3. Complex viscosity, expressed in PA.s, of PDLA solutions at fixed frequencies. 
The numbers between the round brackets indicate the relative change in comparison to the 
viscosity measured in the first run 
ω [rad/s] 1 10 100 
1st run 76.45 36.65 14.26 
2nd run 137.93 (+80%) 57.61 (+57%) 17.87 (+25%) 
3rd run 190.78 (+150%) 76.25 (+108%) 22.20 (+56%) 
 
 
 
 
Table 4.4. Complex viscosity, expressed in PA.s, of PLGA solutions at fixed frequencies. 
The numbers between the round brackets indicate the relative change in comparison to the 
viscosity measured in the first run 
ω [rad/s] 1 10 100 
1st run 1.30 1.18 1.00 
2nd run 3.23 (+148%) 2.84 (+140%) 2.09 (+109%) 
3rd run 10.38 (+698%) 7.59 (+543%) 4.17 (+317%) 
 
 
PDLA solution complex viscosity presents the typical polymer solution 
trend, that is a non-Newtonian pseudoplastic behaviour: the viscosity 
decreases at increasing frequencies. 
Instead, PLGA solutions in the considered frequency present an almost 
Newtonian behaviour. 
In view of the fact that the polymers chemical structures are quite similar 
the viscosity value is highly dependent on the polymer molecular weight24 
and for this reason the measured complex viscosity of of the lower 
concentration PDLA solution is higher than PLGA.  
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Besides, comparison between the increasing values of viscosities of PDLA 
and PLGA polymer solutions after successive tests reveals that evaporation 
was more pronounced in PLGA solution. As a result, PLGA solution was 
therefore more unstable to be processed inside the microfabrication system 
and the whole scaffold production process was less reproducible. This 
problem was technically verified during the microfabrication process: 
unfortunately it was not possible to solve it by increasing the polymer 
solution concentration because the solution quickly converted into a gelly 
state as the concentration was increased.  
Furthermore it is important to underline that the results obtained by the 
rheological tests performed on the solutions are related to the flow viscosity 
(shear stresses). However, especially in small capillary and in non-
Newtonian fluids (such as polymer solutions), the contribution of 
extensional viscosity is also present. Extensional viscosity (or elongational 
viscosity) is the resistance to flow in a stretching deformation. It is 
independent of shear viscosity for non-Newtonian fluids and can be hundred 
times larger24,25.  
4.4.3 Molecular weight distributions of PDLA 
and PLGA polymers 
Molecular weight distribution of PDLA and PGLA base powders, cast films 
and microfabricated scaffolds was evaluated in order to identify any 
possible material modification induced by the process. 
Processes where polymer solutions undergo to shear stresses were 
occasionally reported to induce polymer degradation phenomena which are 
evidenced as a reduction of the molecular weight 26-28.  
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The results of the GPC analyses are presented in Figure 4.15 and Figure 
4.16, which show the molecular weight distributions of PDLA and PLGA 
based materials, respectively, and in Table 4.5, which contains the 
calculated weight average molecular weight and polydispersity index for 
each tested material. 
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Figure 4.15. Molecular weight distribution of PDLA based materials: base powder, cast 
film and microfabricated scaffold 
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Figure 4.16. Molecular weight distribution of PLGA based materials: base powder, cast 
film and  microfabricated scaffold 
Table 4.5. Weight average molecular weight and polydispersity index for PDLA and PLGA 
based materials 
 Mw [kDa] pdi 
PDLA powder 252 2.03 
PDLA microfabricated 206 1.83 
PDLA film 177 1.88 
PLGA powder 39.4 4.20 
PLGA microfabricated 28.6 2.19 
PLGA film 29.3 2.45 
 
 
Figure 4.15 evidences as the molecular weight distributions of the cast film 
and the microfabricated scaffold of PDLA and PLGA shift to lower values 
in comparison to the base powder of both the polymers: this fact 
corresponds to lower weight average molecular weights observed in Table 
4.5. In particular the decrease is more evident for PDLA cast film compared 
to PDLA scaffold. Moreover, the polydispersity index results to be lower in 
Film 
Scaffold 
Base powder 
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the case of the cast film and the microfabricated scaffold: this fact 
corresponds to a narrowing of the molecular weight distribution evidenced 
in Figure 4.15 and Figure 4.16.  
These degradation phenomena could be attributed to the hydrolytic 
degradation typical for poly(α-hydroxyacids)29-34. Being the DMF solvent 
highly hygroscopic35, some water could be present and contribute to easily 
degrade the polymer. In fact, after processing, as proved by the ATR-FTIR 
spectra (chapter 4.4.5), DMF is still present inside the products, scaffolds 
and films. Removing of DMF from scaffolds and film resulted complicated 
and evaporation after process was ineffective because of the high boiling 
temperature of DMF. 
Reduction of glass transition temperatures (Tg), noticed in the DSC 
thermograms also cooperates to confirm the DMF presence after processing 
(chapter 4.4.4). 
On the other hand, the presence of the solvent resulted not to have 
consequences on biological evaluations performed in vitro: washing with 
ethanol and distilled water before usage in culture tests was enough to 
remove the DMF and the degradation of the polymer is negligible if tests are 
carried out immediately. 
Difference in weight average molecular weight between PDLA scaffold and 
film could be caused by the slower evaporation in the film. Evaporation 
process is dependent on surface area and bulk thickness thus being faster in 
scaffolds than in films. 
The fact that degradation occurred in both film and scaffold, states that the 
shear stresses applied to the polymer solution during spinning were not high 
enough to induce chain breaking. The observed degradation phenomena is 
attributable to hydrolysis of the poly (α-hydroxyacids) chains. 
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4.4.4 Differential scanning calorimetry (DSC) 
Thermal properties of PDLA and PLGA polymers, before and after 
microfabrication process, were evaluated by differential scanning 
calorimetry (DSC) analysis in order to investigate possible material 
modifications due to the process. 
As comparison, cast films obtained from the same solutions were analysed 
as well.  
The resulted thermographs are shown in Figure 4.17 and in Figure 4.18. 
Table 4.6 shows the evaluations results. 
A first heating scan from 0°C to 100°C was made to remove solvent traces. 
PDLA and PLGA are amorphous polymers and the base powders show a 
second order phase transition, i.e. glass transition temperature (Tg) at 
57,36ºC and 46,49°C, respectively.  
Tg of microfabricated scaffold and film is lower. During the first heating 
scan the decrease is due to residual solvent inside the material acting as a 
plasticizer for the polymer36, lowering down the Tg. Infrared spectroscopy 
analysis (chapter 4.4.5) confirmed the presence of DMF solvent. 
Considering the second heating scan curves, Tgs drop in the microfabricated 
polymers from 57,36 to 54,80°C, and from 46,49 to 42,72°C, for PDLA and 
PLGA polymers respectively. 
These results are consistent with the already presented molecular weight 
findings (chapter 4.4.3), which have shown a degradation of the polymers in 
the microfabricated scaffolds. 
Similar considerations can clarify cast film results at the same way. 
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Figure 4.17. Thermographs related to PDLA grains (A) and PDLA microfabricated scaffold 
(B) 
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Figure 4.18. Thermographs of PLGA grains (A) and PLGA microfabricated scaffold (B) 
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Table 4.6. DSC results for PDLA and PLGA grains, film and microfabricated scaffold 
 
 1st scan 2nd scan 
PDLA 
raw 
material 
Tg 57.56°C 57,70°C 
PDLA 
Film 
Tg 36.72°C 46.47°C 
PDLA 
scaffold 
Tg 29.94°C 54.80°C 
PLGA 
raw 
material 
Tg 54.69°C 46.49°C 
PLGA 
Film 
Tg 7.66°C 14.73°C 
PLGA 
scaffold 
Tg 22.54°C 43.72°C 
 
PLGA based grains during the first heating scan showed a first-order phase 
transition, i.e. an endothermic peak (Figure 4.18, A), just after Tg. This peak 
corresponds to the enthalpy involved in the relaxation of the more mobile 
polymer chains after Tg due to densification occurred during the polymer 
cooling but also storage. Densification reduces free volume and hence 
mobility of the glassy domains: the sudden increase in free volume at Tg 
enables the polymer chains relaxation if energy is furnished. This 
phenomenon is not present in the polymers second scan, being aging related, 
neither in the scaffold or cast film materials, due to the plasticing effect of 
the residual solvent 37.  
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4.4.5 Attenuated total reflection infrared 
spectroscopy (ATR-FTIR) 
Attenuated total reflection infrared (ATR-IR) spectroscopy analysis was 
used to identify spectra associated to the polymers before and after 
microfabrication process to evidence any possible variation inside the 
starting polymer chemical structure due to the process. Cast films from the 
same polymer solutions were analysed as well. 
Both PDLA and PLGA spectra are reported in Figure 4.19 and Figure 4.20, 
respectively. The spectrum relative to DMF solvent is added.  
Absorption peak near 1670 cm-1, typical for Amide I stretching vibration 
and characteristic for DMF solvent, reveals the presence of trapped solvent 
(DMF) inside the microfabricated scaffolds and cast film as previously 
shown by thermal analysis. 
 
 
Figure 4.19. ATR spectra of PDLA a) powder, b) film, c) microfabricated scaffold, d) DMF 
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Figure 4.20. ATR spectra of PLGA a) powder, b) film, c) microfabricated scaffold, d) DMF 
4.4.6 Dynamic mechanical thermal analysis 
(DMTA) 
Dynamic mechanical thermal analysis (DMTA) on PDLA and PLGA 
scaffold and cast film was performed to characterize the thermomechanical 
behavior of the polymeric products and to reveal differences in transition 
temperatures. 
This practice is intended to provide means of determining the transition 
temperatures, elastic and loss moduli of the microfabricated scaffolds and 
films over the chosen range of temperatures at a specific frequency. 
Plots of the storage modulus and loss factor are indicative of the viscoelastic 
characteristics of the polymer. These moduli are functions of temperature or 
frequency in polymers and change rapidly at particular temperatures or 
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frequencies. The regions of rapid modulus change are normally referred to 
as transition regions. 
Figure 4.21 and Figure 4.22 show the storage modulus and loss factor as a 
function of temperature for PDLA and PLGA, microfabricated scaffolds and 
cast films, respectively. 
In general microfabricated scaffold storage modulus for both polymers is 
quite low if compared with cast films, but this is simply due to the fact that 
in microfabricated scaffolds the resisting cross section is lower than the 
nominal one. 
Decreasing of the storage modulus, which corresponds to a peak in the loss 
factor trend, indicates the glass transition temperature of the amorphous 
polymers. The value is particularly low because of the residual solvent still 
present inside the polymer, as stated before (chapter 4.4.5) which acts as a 
plasticizer thus reducing the Tg value. Tg values obtained by this 
characterization are lower than DSC, this fact being due to the lower heating 
rate in the DMTA. 
In Figure 4.21 (B), the modulus E’ of PDLA sharply decreases when 
temperature approaches the glass transition at about 20°C. Parallel to this, 
the loss factor increases until reaching a maximum value at about 30°C, that 
is identified as the glass transition temperature.  
Notwithstanding, the loss factor doesn’t evidence a sharp peak as in the case 
of the other materials because of technical problems. 
PLGA scaffold storage modulus is extremely low, near the lower limit of 
the sensitivity of the apparatus and the first range of values at lower 
temperatures has to be neglected (Figure 4.22). 
Around 30°C, the E’ shows for the PLGA sample a peak just before the 
drop due to the glass-rubber transition (Tg). This small peak reflects some 
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stiffening of the PLGA material preceding the Tg. This effect can be 
observed mostly in an amorphous material, and it has the origin in 
relaxation of internal stresses frozen during melt quenching38-41. 
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Figure 4.21. Plots of storage modulus and loss factor for PDLA microfabricated scaffold 
(A) and cast film (B) as a function of temperature 
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Figure 4.22. Plots of storage modulus and loss factor for PLGA microfabricated scaffold 
(A) and cast film (B) as a function of temperature 
A 
B 
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4.4.7 Preliminary in vitro culture studies 
Human osteosarcoma derived osteoblasts (MG63) and human embrional 
lung origin fibroblasts (MRC5) cell lines were seeded on microfabricated 
PDLA and PLGA scaffolds. 
Cell attachment, growth and distribution over the chosen micro structured 
matrices, at two time points, was evaluated by SEM imaging. 
In particular cells adhesion and their ability to enter into pores and 
proliferate also inside the micro structure was evaluated. 
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PDLA microfabricated scaffolds: 
 
Figure 4.23 shows SEM imaging of an osteoblast (MG63) cell line culture 
on PDLA microfabricated scaffold after 7 days (A and B) and 14 days (C 
and D) of cell culture. 
 
Osteoblast (MG63) grew extremely fast and after 7 days they were able to 
entirely cover the PDLA structure. 
 
  
  
Figure 4.23. SEM images of PDLA scaffold after 7 days (A and B) and 14 days (C and D) 
of osteoblast MG63 cell culture; the marker indicates 100 µm 
 
A B 
C D 
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Figure 4.24 reports the SEM imaging of fibroblasts (MRC5) cell culture on 
PDLA microfabricated scaffold after 7 days (A and B) and 14 days (C and 
D) of cell culture. 
Growing for fibroblasts was slower, with part of the PDLA scaffold still 
uncovered after 7 days culture. 
 
 
  
  
Figure 4.24. SEM images of PDLA scaffold after 7 days (A and B) and 14 days (C and D) 
of fibroblasts MRC5 cell culture; the marker indicates 100 µm 
 
To evidence the ability of cells to grow also inside the three dimensional 
structure were unfolded and SEM imaging of the inner part were taken. 
Figure 4.25 and Figure 4.26 show the internal part of a scaffold seeded with 
osteoblasts (MG63) and fibroblasts (MRC5), respectively.  
A B 
C D 
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In both cases, osteoblasts and fibroblasts could invade the inner part of the 
scaffolds, with cells adhering to single filaments or bridging between 
different filaments of the pore walls. In general, osteoblasts penetrated the 
scaffolds more than fibroblasts, confirming their faster growth as observed 
on the scaffold external surfaces. No modifications of the scaffold geometry 
and integrity were detectable after 14 days of cells culture. 
 
 
 
 
 
 
 
Figure 4.25. SEM images of inner layers of PDLA microfabricated scaffold after 
osteoblasts MG63 cell seeding (7 days); (A) PDLA microfabricated scaffold before 
seeding, chapter 4.4.1, (B, C) different magnifications; markers indicate 30 µm (B) and 100 
µm (C) 
 
 
 
 
A 
B C 
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Figure 4.26. SEM images of inner layers of PDLA microfabricated scaffold after MRC5 
cell seeding (7 days) ; (A) PDLA microfabricated scaffold before seeding, chapter 4.4.1, 
(B, C) different magnifications markers indicate 10 µm (B), 30 µm (C) and 100 µm (D) 
 
 
 
 
A 
B C 
D 
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PLGA microfabricated scaffolds: 
Cell culture tests on PLGA microfabricated scaffold were performed and 
SEM imaging evaluation was done at day 7 and 14. 
Figure 4.27 and Figure 4.28 show the SEM imaging results for osteoblasts 
and fibroblasts cell culture, respectively. 
PLGA scaffolds were fully covered by a cell layer that was quite denser in 
the case of osteoblasts. 
No evidence of cell migration inside the scaffold could be detected, this 
being however due to the more compact structure of the PLGA scaffolds 
with respect to the PLDA. After 14 days culture, evident signals of 
degradation were visible. 
 
 
Figure 4.27. SEM images of PLGA scaffold after 7 days (A and B, different 
magnifications) and 14 days (C and D, different magnifications) of osteoblasts (MG63) cell 
culture; in all the micrographs markers indicate 100 µm 
A B 
C D 
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Figure 4.28. SEM images of PLGA scaffold after 7 days (A and B) and 14 days (C and D) 
of fibroblasts MRC5 cell culture; in all the micrographs markers indicate 100 µm 
 
 
 
 
 
B A B B 
B 
D C 
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4.5 Results and Discussion: microfabrication of 
chitosan scaffold 
4.5.1 Microfabrication of chitosan scaffold  
Microfabrication of chitosan scaffold was conducted starting from 3% (w/v) 
chitosan solution. 
The final matrix is composed by 80 overlapped layers resulting in a well 
ordered geometry structure having 170 µm large square holes and thickness 
of about 100 µm. 
Figure 4.29 shows the optical microscope imaging of a microfabricated 
scaffold. 
  
Figure 4.29. Optical microscopy imaging of 80 layer chitosan scaffold  
 
The usage of chitosan material in robotic dispensing systems (RPBOD) but 
at a different scale level compared to the microfabrication technique has 
been widely studied by other research groups42. 
  
   
  150µm 
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These studies revealed the necessity to use sodium hydroxide (NaOH) as a 
dispensing medium to neutralize chitosan thus forming a gel-like 
precipitate. 
In our first attempts we tried to microfabricate chitosan scaffolds extruding 
the polymer solution directly into a sodium hydroxide-ethanol solution but 
the micrometric fibres couldn’t attach to each other forming the final 
scaffold. Comparing the microfabrication technique with other RP systems, 
the extruded filament has reduced micrometric dimensions and fibres 
floated in the medium. On the other side, the high evaporation of the solvent 
did not require precipitating the extruded filament in sodium hydroxide to 
make it solid. 
Chitosan scaffolds were thus prepared by microfabrication on a PET sheet 
and later on treated with NaOH instead of using a coagulation medium. 
Figure 4.30 shows LV-SEM imaging of microfabricated chitosan scaffolds. 
The final matrix resulted very thin even after 80 layers of deposition, with a 
film shape appearance; this is due to the low concentration of the starting 
chitosan solution. 
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Figure 4.30. LV-SEM imaging of 90 layer chitosan scaffold at different magnifications 
 
In general, the produced chitosan scaffold was kept in 1 M NaOH for one 
hour to neutralize the acetic acid and then washed with distilled water 
After the neutralization and washing steps, the samples were examined with 
LV-SEM and the photographs are presented in Figure 4.31. 
It can be observed that chitosan scaffolds, even after few deposited layers 
(20 in this specific case), maintained their shape and a regular structure after 
NaOH treatment. As the previous one, the layers stuck to each other 
forming a membrane structure.  
 
 
A B 
C D 
A 
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Figure 4.31. LV-SEM imaging of 20 layer chitosan scaffold at different magnifications 
after Na OH treatment 
 
Preliminary in vitro cultures studies with osteoblasts MG63 cell line were 
conducted on microfabricated chitosan scaffolds. 
Chitosan scaffolds, which were not treated with NaOH, broke into pieces 
after 7 days of cell seeding as shown in Figure 4.32. 
Without NaOH washing the non neutralized material resulted to be not 
stable. Furthermore cells were not present on the scaffold surface owing to 
acetic acid still present inside the material and not completely washed away; 
this made the material not biocompatible and suitable for cells adhesion. 
C D 
B A 
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Figure 4.32. SEM imaging of chitosan scaffold without NaOH treatment after preliminary 
in vitro culture studies with osteoblast MG63 cell line after 7 days 
 
 
 
4.5.2 Nuclear magnetic resonance (NMR) 
13C CP-MAS NMR spectroscopy has been revealed to be a good method to 
identify the degree of acetylation of chitin and chitosan43. 
The chemical behaviour of chitin and related materials strongly depends on 
the degree of aceticaltion (DA), a parameter defined as the mole fraction of 
acetylated units in the polymer chain20.  
Among all the available techniques commonly used to determine the DA 
value21,43, 13C nuclear magnetic resonance (NMR) spectroscopy is one of the 
most powerful, allowing a direct determination of DA of both soluble and 
non-soluble samples; no specific sample preparation is needed. 
13C CP-MAS spectrum of chitosan powder is given in Figure 4.33. 
A B C 
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At 105.033 ppm, the resonance of the anomeric carbon C(1) of the 
glucosamine unit is observed. The resonances at 174.555 ppm and 23.735 
ppm are attributable respectively to the carbonyl C(7) and to the methyl 
C(8) of N-acetylglucosamine units while the resonances at 61.147 ppm and 
58.284 ppm to C(6) and C(2) correspondingly. At 75.553 ppm, a set of 
overlapped resonances is due both to C(3) and C(5). C(4) resonates at 
82.698 ppm. 
 
 
Figure 4.33. 13C CP-MAS NMR spectra of chitosan 
 
Chemical shifts of chitosan are given in Table 4.7.  
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Table 4.7. Chemical shifts of chitosan obtained by 13C CP-MAS NMR 
Functional group Chemical shift 
C=O 174.555 
C1 105.033 
C4 82.698 
C3 75.553 
C6 61.147 
C2 58.284 
CH3 23.735 
 
13C solid-state NMR appears to be the most reliable for the evaluation of the 
acetyl content. The degree of acetylation (DA) is usually calculated by 
measuring the integral of the carbonyl or methyl group divided by the 
integral of all the carbon atoms in the backbone. 
 
In this study, the degree of acetylation was evaluated from the relative 
integrals of methyl group compared to the carbon integrals of the 
polysaccharidic backbone. The degree of acetylation of chitosan used was 
found as 22%. 
4.5.3 Rheological test on Chitosan solution 
Chitosan solution flow behaviour was characterized by rheological tests and 
a proper working range of viscosity, in respect to the microfabrication 
process, was determined. 
Shear viscosity over a chosen frequency range between 1 and 100 rad/s was 
measured. 
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Figure 4.34 shows the resulted graphs; in particular average complex 
viscosity is reported in Figure 3.34 A and solvent evaporation was evaluated 
comparing the viscosity variations after three following tests, Figure 3.34 B. 
Table 4.8 reports the numerical values of viscosities at specific frequencies. 
In respect of chitosan solution, a significant evaporation was not expected 
since boiling point of water and acetic acid (118oC) are quite high. Chitosan 
solution showed a complex viscosity that remains almost constant 
(Newtonian behaviour) over the selected frequency range. 
Chitosan solution at the chosen solution concentration is therefore very 
stable, because the viscosity does not depend on the imposed frequency and 
the solvent evaporation can be neglected. For this reason chitosan solution 
yields to reproducible tissue engineering scaffolds.  
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Figure 4.34. Complex viscosity plotted over frequency. (A) average viscosity (B) solvent 
evaporation evaluation 
Table 4.8. Viscosity values of Chitosan solution at chosen frequency values 
Test frequency [rad/sec] Viscosity [Pas] 
1 1.28 
10 1.00 
100 0.74 
A 
B 
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4.5.4 Differential scanning calorimetry (DSC) 
Differential scanning calorimetry analysis (DSC) was performed on the base 
chitosan powder and on the microfabricated scaffold to evidence material 
transitions and evaluate any possible modification of polymer due to the 
process. 
Cast film was analysed as well as control. 
DSC thermograms of chitosan powder, film and microfabricated scaffolds 
are presented in Figure 4.35. 
Table 4.9 reports the evaluated values related to material transitions 
obtained by DSC analysis. 
The graphs evidence a broad endothermic peak close to 100oC, attributed to 
evaporation of residual water or solvent, eliminated during the first heating 
scan. 
The exothermic peak at approximately 300°C, according with previous 
studies44,45 was due to the degradation of the main chain. 
Glass transition temperature of chitosan is not clearly detectable from the 
graphs even if a weak signal can be observed at around 200°C, especially in 
chitosan film sample. In general Tg in chitosan is a subject of controversy. 
Being a natural polymer some properties like crystallinity, molecular 
weight, deacetylation degree can show wide variations according to the 
source and/or method of extraction and will influence the Tg.  
Considering the starting heat of evaporation of pure water and acetic acid, 
2257 J/g and 402 J/g respectively, the resulting heat of evaporation of 
5%v/v acetic acid solution is 2164 J/g. From the integral of endothermic 
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evaporation peaks in the first runs the amount of water (in powder) or 
solvent (film and microfabricated scaffold) evaporated is calculated and the 
degradation exothermic peak is normalized to the actual mass involved 
during transformation.  
Some differences between powder, film and scaffold related to the 
degradation process were detected; in particular degradation in chitosan 
powder occurred at higher temperature and bigger amount of material was 
involved.  
Since film and scaffold showed a similar behaviour, it is possible to state 
that there was not a significant degradation associated to the 
microfabrication process. 
For our purposes we are not interested in knowing specifically the kinetic of 
degradation happening to the polymer at high temperatures and which 
would require additional analysis. Conversely identifying any possible 
alteration occurring to the material due to the microfabrication process is of 
main interest in this work. 
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Figure 4.35. Thermographs of Chitosan powder first run (B) and second run (A). Chitosan 
film first run (D) and second run (C). Chitosan microfabricated scaffold first run (F) and 
second run (E)  
 
Table 4.9. Transformations main values after DSC analysis of Chitosan powder, film and 
microfabricated scaffold 
+ Powder Film Scaffold 
Initial weight 
[mg] 9.6 10.3 5.5 
Run 1st 2nd 1st 2nd 1st 2nd 
Onset 
Temperature 
[°C] 
48 290 52 261 50 266 
Integral 
[mJ] 1828 1222 2091 872 767 425 
Evaporated mass 
[mg] 0.8  0.96  0.35  
Normalized 
integral 
[J/g] 
 139  93  83 
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4.5.5 Attenuated total reflection infrared 
spectroscopy (ATR-FTIR) 
Infrared Spectroscopy analyses were performed on chitosan powder, cast 
film and microfabricated scaffold to evidence possible modifications due to 
the process. 
ATR spectra of chitosan film, powder and microfabricated scaffold are 
given in Figure 4.36. 
The spectra are comparable and no considerable differences can be 
observed. 
The absorption bands observed at 1580 and 1645 cm−1 are due to the –NH 
bending vibration in amine groups and the stretching vibration of C=O 
amide bond, respectively. The absorption at about 1645 cm−1 is typical of 
non-deacetylated bonds of chitosan. The broad peak at 2860 cm−1 may be 
attributed to C-H stretching vibrations and -H stretching linked to cyclic 
ring. The peak at 3300 cm−1 is due to OH linked to polymer. 
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Figure 4.36. ATR spectra of chitosan a) powder, b) film and c) microfabricated scaffold 
 
4.5.6 Dynamic mechanical thermal analysis 
(DMTA) 
The dynamic-mechanical thermal analysis (DMTA) of polymeric materials 
in general is of great interest resulting from its great sensitivity in detecting 
transitions and changes of internal molecular mobility and in probing a 
phase structure and morphology of polymers. 
DMTA thermographs reveals relaxation phenomena through peaks in loss 
factor curve. The main of them are known as α and β relaxation. The β 
relaxation has been assigned to the local mode of relaxation in the 
amorphous phase. The α relaxation related to the glass transition of the 
amorphous phase is controlled by both intra- and intermolecular 
interactions. It is accompanied by a distinct decrease of the storage modulus 
E’ with increasing temperature and the presence of E’’ peak. 
2860 cm-1 
CH stretching  
vibrations 
1645 cm-1C=O amine bond stretching 
stretching vibration 
1580 cm-1 
-NH bending vibration 
3300 cm-1 
OH linked to polymer 
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DMTA was performed on chitosan scaffold and cast film, as comparison, to 
evidence the main material transitions. 
Storage modulus (E’) and loss factor (Tan δ) curves as a function of 
temperature of chitosan film and scaffold are given in Figure 4.37. 
In particular the transition at about -18oC could be attributed to β relaxation, 
representing a local motions of side groups in chitosan, while the peak at 
150oC – 178oC was related to α relaxation, which is Tg of chitosan.  
DMTA analysis usually shows Tg transitions much more evident if 
compared to DSC analysis due to drastic drop of E’. Furthermore in our 
specific case a slower heating rate (3oC/min) during DMTA analysis caused 
a lower Tg. When heating rate is faster there is not enough time for the 
polymer to dissipate heat energy along the polymer chains and Tg is 
observed at higher temperature. 
Storage modulus showed a minimum value at 40°C. This can be explained 
as a structural reorganization of packing of chitosan molecules due to an 
increase of residual water mobility, volume expansion and change of 
hydrogen bond strength. 
As expected in the case of chitosan scaffold the modulus was lower than the 
film since the scaffold has a porous weaker structure. 
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Figure 4.37. DMTA thermographs of chitosan scaffold (A) and cast film (B) 
A 
B 
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4.5.7 Preliminary in vitro culture studies 
After stabilization with NaOH treatment, the produced chitosan scaffold 
underwent to preliminary in vitro culture studies. 
Cancerous osteoblasts (MG63) and fibroblast (MRC5) cell lines were 
seeded on the microfabricated chitosan scaffolds. 
Two different time points were chosen: 4 and 10 days. 
SEM imaging evaluated scaffold and cell morphology as well as cell 
attachment and growing.  
Figure 4.38 and Figure 4.39 show SEM imaging of scaffolds after chosen 
time points of in vitro osteoblasts and fibroblasts cell culture. 
It can be observed how scaffolds maintained their shape during cell culture. 
Cells could spread, attach and grow on the microfabricated scaffolds 
confirming the biocompatibility character of the material; moreover pores 
were easily invaded by cells. 
In general, as previously observed for synthetic polymer scaffolds, 
osteoblasts grew faster than fibroblasts. 
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Figure 4.38. SEM imaging of chitosan microfabricated scaffold after 4 days (A, C, E) and 
10 days (B, D, F) cell seeding with MG63 cell line. A, B, C, D, E, F different 
magnifications 
 
As shown in Figure 4.38 (B, D, F) some chitosan scaffolds didn’t show a 
porous structure. The firsts layers could sometime spread entirely on the 
substrate and the following layers formed on this first chitosan film. The 
A 
C 
E 
B 
D 
F 
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reason for this difference could be attributed to variations in environmental 
conditions such as temperature or air humidity.  
 
 
 
 
Figure 4.39. SEM imaging of chitosan microfabricated scaffold after 4 days (A, C, E) and 
10 days (B, D, F) cell seeding with fibroblasts MRC5 cell line. A, B, C, D, E, F different 
magnifications 
A 
C 
B 
D 
E F 
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4.6 Results and Discussion: microfabrication of 
chitosan ACP scaffolds 
Amorphous calcium phosphate (ACP) is the precursor of hydroxyapatite in 
bone mineral46. The important release of Ca2+ and PO4 ions associated to 
ACP is favorable to apatite formation. 
Methacrylate-based composites with ACP demonstrated how this material 
could promote the recovery of mineral deficiencies in tooth structures being 
able to in vitro remineralize carious enamel lesions47. 
The formation of “non-crystalline” calcium phosphate is a kinetic 
phenomenon48. The rapid mixing of the reaction solutions creates strong 
interactions between Ca2+ and HPO42- ions, leading to irregular co-
ordination complexes large enough in phase to separate from the solution. 
The following temperature-dependent transformation into apatite indicates 
that this initial phase is isothermally metastable with respect to the more 
ordered apatite configuration. The conversion mechanism of ACP to apatite 
is auto-catalytic: the interfacial surfaces of the emerging crystalline phase 
act as sites for heterogeneous nucleation, thereby accelerating the rate of 
conversion. Besides, the amorphous phase remains stable indefinitely if kept 
dry since water is fundamental in the nucleation process. 
Pyrophosphate P2O74- ions were also used to stabilize ACP material to retard 
the conversion to apatite in dental applications23. 
Thinking at the osteoinductive character of ACP particles, their combination 
with chitosan was investigated to produce microfabricated scaffolds with 
osteoconductive properties for bone tissue regeneration. 
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Rheological tests were used to evaluate viscosity changes between pure 
chitosan and chitosan filled with ACP, to identify the optimal viscosity 
range values to use inside the RP system. 
Washing the produced scaffold by NaOH was fundamental to expose the 
particles to the surface, to put them directly in contact with the biological 
environmental. EDS analysis together with LV-SEM imaging confirmed the 
effectiveness of the washing process. 
Using osteoblasts cell line MG63 preliminary in vitro culture studies were 
performed; cell morphology, attachment and growth were evaluated by 
SEM analyses.  
Finally AFM imaging was used to measure the final particles size and their 
distribution in the chitosan matrix. 
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4.6.1 Microfabricated scaffold 
Chitosan scaffold filled with ACP particles having a well ordered structures 
were microfabricated as films 100µm thick containing 100 microns square 
pores (Figure 4.40).  
80 overlapped layers composed the resulting scaffolds. 
The selected process parameters to develop the scaffolds were fixed 
according to the ones used during pure chitosan scaffolds production. 
 
 
Figure 4.40. SEM images of Chitosan filled wih ACP microfabricated scaffold 
 
4.6.2 Rheological tests 
Evaluation of viscosity changes between pure chitosan solution and chitosan 
solution filled with ACP particles was performed by rheological tests. 
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Complex viscosity trends as a function of frequency are plotted in Figure 
4.41. 
Both the solutions show the typical polymer solution behavior; being non-
Newtonian fluids the viscosity decreases with frequency. In the detail, the 
viscosity of a particle loaded suspension resulted to be lower than the 
viscosity of unloaded solution: in fact, the complex viscosity measured at 
the frequency value of 10 rad/sec (that is in the Newtonian region) for plain 
chitosan solution was 1.00 Pas while for the chitosan/ACP solution was 0.48 
Pas, that is a reduction of 52%. 
The viscosity of a suspension should increase for dilute concentration 
following the Einstein’s theory 49. In our case the viscosity decreased, and 
this is just due to the lower chitosan concentration in the suspension.  
In fact, the suspension contained ACP-chitosan 0.4%-2.6%  while the 
solution was at 3% chitosan. This choice was made to maintain constant the 
total amount of solid material in the solution (i.e. 3wt%) in order to produce 
microfabricated scaffolds with the same amount of material. Nevertheless, 
the viscosity reduction is quite high and could not be entirely attributed to 
the reduced polymer concentration, but to imprecise interactions between 
the partially dissolved filler and the polymer chain. 
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Figure 4.41. Comparison between viscosity of pure Chitosan solution and Chitosan filled 
with ACP particles solution 
4.6.3 Thermogravimetric analysis (TGA) 
Thermogravimetric analysis (TGA) was performed on pure chitosan, 
chitosan filled with ACP particles (composite) and ACP particles. 
Figure 4.42 shows the thermographs resulted from thermal analysis test. 
As expected, the ceramic phase evidence a limited weight loss, i.e. about 
10% at 800°C. In detail, ACP presented the humidity water release at about 
100°C (that corresponded to about 3%), a progressive weight loss between 
200 and 400°C related to dehydroxylation phenomena and, finally, a sharp 
weight loss between 400 and 600°C related to the condensation of 
hydrogenophosphate ions50,51. On the contrary, chitosan evidenced a sharp 
weight loss at about 290°C that corresponds to degradation phenomena in 
Chitosan  
 
Chitosan/ACP 
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good agreement with DSC analysis (see chapter 4.5.4). Moreover, chitosan 
evidenced a sharp weight loss of 8% at about 110°C due to the loss of the 
adsorbed water. 
Chitosan ACP composites were characterized by the absence of the weight 
drop related to the release of the absorbed water. Moreover, the degradation 
phenomena at about 290°C related to the polymeric phase (i.e. the chitosan) 
was still present, but in a broader temperature range. In fact, even if the 
maximum intensity of the phenomena is at 290°C in both the cases, the 
onset moved down from 270 to 200°C. This fact is in agreement with the 
existence of some unclarified interactions between the polymer and the 
ACP. 
 
Figure 4.42. TGA thermograph related to pure chitosan, chitosan filled with ACP and pure 
ACP particles 
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4.6.4 Preliminary in vitro culture studies 
Human osteosarcoma derived osteoblasts cell line MG63 were cultured  on 
microfabricated chitosan/ACP. The seeded scaffolds were observed by SEM 
analysis after two different time points (4, 10 days) (see Figure 4.43 and 
Figure 4.44). 
Initially, osteoblasts spread preferentially on the top part of the scaffold, 
then migration in the pores region could be observed: cells were able to 
extend philopodia inside the pores. 
 
 
 
Figure 4.43. SEM images of Chitosan filled with ACP microfabricated scaffolds after 4 
days cell seeding with MG63 
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Figure 4.44. SEM images of Chitosan filled with ACP microfabricated scaffolds after 10 
days cell seeding with MG63 
4.6.5 Energy dispersive spectroscopy (EDS)  
Energy dispersive spectroscopy (EDS, EDAX) was used to identify 
elemental composition of chitosan/ACP scaffold surfaces, before and after 
washing with NaOH. 
The aim of the analysis was to reveal the effectiveness of washing samples 
with NaOH in order to expose ACP particles to the surface, thus improving 
the osteoinductive character of the scaffold.  
The surface analysis was conducted in combination with environmental 
scanning electron microscopy (LV-SEM) imaging. 
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During microfabrication process the ACP particles are trapped inside the 
chitosan matrix for surface energy implications. 
NaOH washing removed the outside chitosan layer so exposing some ACP 
particles. 
Figure 4.46 and Figure 4.48 show the EDS spectra of chitosan/ACP 
scaffolds, non-washed and washed with NaOH, respectively. Tables 
reporting the weigh fraction of the detected element composition on the 
surface, related to each spectrum, revealed that washed samples contained 
on the surface higher quantities of phosphate and calcium than non-washed 
samples. In the specific case the phosphate and calcium content of non-
washed sample is 1.21 and 3.00 wt%, respectively, while, in the case of 
washed samples the values increases to 2.90 and 5.46 wt%. 
Generally the depth of the analysis in the sample is dependent on the applied 
voltage 52,53 but still superficial; in our case , this semi-quantitative analysis 
confirms the efficacy of NaOH washing to expose higher quantities of 
calcium phosphate to the surface.  
Figure 4.45 and Figure 4.47 are the associated LV-SEM imaging. 
 
 
 
 
Figure 4.45. E-SEM imaging of chitosan filled with ACP particles before NaOH washing 
treatment 
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Figure 4.46. EDS spectra and semi-quantitative analysis of chitosan/ACP scaffold surface 
non-washed by NaOH 
 
Figure 4.47. E-SEM imaging of chitosan filled with ACP particles after NaOH washing 
treatment 
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Figure 4.48. EDS spectra and semi-quantitative analysis of chitosan/ACP scaffold surface 
washed by NaOH 
Figure 4.49 shows the overlapped EDS spectra of washed and non-washed 
scaffold.  
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Figure 4.49. EDS overlapped spectra of chitosan/ACP scaffold washed and non washed 
 
4.6.6 Atomic Force Microscopy 
Atomic force microscopy (AFM) analysis was performed on scaffold 
surface after NaOH washing treatment to analyze the topography of the 
surface and to measure surface exposed ACP particle size. 
Evaluation of possible reductions in dimensions due to a combination of an 
erosion mechanism together with ACP dissolution was considered. 
Figure 4.50 and Figure 4.51 show the topography of the scaffold surface. To 
better evidence the particles a Prewitt vertical filter was applied. 
Figure 4.52 is a three dimensional view of the previous surface. 
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Measurement of the particle size was also performed and Figure 4.53 and 
Figure 4.54 show the topography of the surface analyzed and the surface 
height profile, respectively. 
The biggest visible particles, had a size of about 600 nm. A reduction of the 
particles size is thus evidenced if compared with the starting particle size. 
Erosion and/or solubilization followed by recrystallization are the possible 
phenomena responsible for the reduction of this dimension. 
 
 
Figure 4.50. AFM imaging of chitosan/ACP scaffold surface 
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Figure 4.51. AFM imaging of chitosan/ACP scaffold surface. Prewitt vertical filter applied. 
 
 
Figure 4.52. Three dimensional view of a 10 x 10 µm square area analysed by AFM of a 
chitosan/ACP scaffold surface washed with NaOH 
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Figure 4.53. Topography of chitosan/ACP scaffold surface. The line indicates the selected 
area for the profile analysis 
 
Figure 4.54. Surface height profile 
Dx= 589 nm 
Dy= 1.8 nm 
Angle= 0.17° 
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5 PART 2: fused deposition modelling 
scaffold for human osteoblasts cell 
cultures 
5.1 Abstract 
Human osteoblasts, isolated from the tibial sponge bone, were seeded on 
medical-grade polycaprolactone-tricalcium phosphate (mPCL-TCP 80:20) 
and poly(D, L lactic acid)- tricalcium phosphate (PDLLA-TCP 90:10) 
scaffolds produced by fused deposition modelling (FMD) technique. 
Scanning electron and confocal microscopy was used to characterize the 
cell-substrate interaction over different time points.  
In addition, once the cells had reached the confluent stage, osteogenic media 
was used during cell culture to induce matrix formation. The newly formed 
matrix could provide a physical support forming an osteoblast sheet layer 
that was used to wrap the scaffold. 
Cells viability was evaluated by fluorescein diacetate (FDA)/ propidium 
iodide (PI) staining.  
The extent of cell proliferation was examined by PicoGreenTM 
quantification assay through the calculated cell DNA amount profile. 
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5.2 Introduction 
In tissue engineering (TE) research area living cells, biologically active 
molecules and structural scaffolds are combined together to form a tissue 
engineering construct (TEC) and promote the repair and regeneration of 
tissues. 
One of the main efforts of tissue engineering (TE) is related to the 
development of techniques that can be used to produce scaffolds working as 
structural supports for cell seeding, attachment, growing, proliferation and 
differentiation.  
Among these, rapid prototyping (RP) systems are able to produce scaffolds 
having a well ordered and reproducible structure. Control over scaffold 
geometry and porosity distribution and size is also possible. 
In particular, regarding bone tissue regeneration application, an increasing 
trend has been seen towards the fabrication of polymer –based composite 
materials to obtain matrices having increased osteoconductive properties. 
Producing scaffolds by composite materials combining together polymer 
and ceramic phases nowadays is a followed strategy. In this way better 
mechanical properties are achieved; higher strength is obtain by the ceramic 
phase while toughness and plasticity is gained thanks to the polymeric 
phase. From a biological point of view composite materials provide a 
suitable microenvironment that mimic the host tissue’s inorganic phase 54,55.  
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In this study FDM scaffolds produced from mPCL-TCP and PDLLA-TCP 
composites, developed for bone tissue regeneration, were cell seeded with 
human osteoblasts derived by tibial sponge bone. 
The use of cell-sheet assisted the cell seeding procedure to overcome the 
low surface to volume ratio of these scaffolds. 
Okano’s group developed the use of single sheets of cultured corneal 
epithelial cells and multilayered cardiomyocytes sheets for engineering 
transplantable cornea and myocardial tissues using a smart culture plate 
technology56,57. 
Morphology of the scaffolds, cells distribution and growing was revealed by 
confocal laser microscope (CLM) and scanning electron microscopy (SEM) 
imaging at different time points. Viability of cells was investigated by 
confocal laser imaging. A proliferation analysis was evidenced by 
PicoGreenTM quantitation assay. 
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5.3 Materials and Method 
5.3.1 FDM scaffolds 
Scaffolds of mPCL-TCP (80:20) and PDLLA:TCP (90:10) with a lay-down 
pattern 0/60/120° produced via fused deposition modelling (FDM) 
technique were cut into pieces having a 80 mm2 cross sectional surface 
area58. 
5.3.2 Cell culture 
Osteoblasts were isolated (with patient consensus) from tibial sponge bone. 
The bone chip explants ware placed in a tissue culture flask until osteoblast 
outgrowth was observed. Once 80% confluence had occurred, the cells were 
trypsinized two times. 
All the FDM scaffolds were sterilized by immersion in 70% ethanol. 
Cell culture was performed by seeding each scaffold with 50000 cells 
concentrated in a volume of 20 µl. After 2h of incubation, required for cell 
attachment, the medium was added to each well and changed three times per 
week. 16000 cells/cm2 were seeded on the monolayer controls. 
Five time points were chosen: 2, 9, 16, 30, 45 days. Till 16 days growing 
media α-MEM (1g/l glucose + glutamine) (Sigma Chemicals, Missouri, US) 
supplemented with 1% antibiotics (100 IU mL-1 penicillin and 100µg mL-1 
streptomycin) and 10% Fetal Calf Serum (FCS) was used. After confluence, 
at day 16, culture media was changed and osteogenic induction was 
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conducted through the use of supplemented media containing 10 nM 
dexamethasone (Dex), 100 mM β-glycerophosphate (β-GP) and 50 µgmL-1 
ascorbic acid (AA). Media was changed every 3 days. At day 30 matrix 
formation was enough to obtain osteoblasts sheets that were easily detached 
from the well-plate and used to wrap the scaffolds. 
Figure 5.1 shows the osteoblast sheet detached from the well plate thanks to 
the use of a plastic soft scraper. 
 
Figure 5.1. Osteoblast cell sheet detaching from the 6 well-plate 
5.3.3 Proliferation assays 
To measure the extent of proliferation, cell DNA amount profile was 
calculated, at each time-points by PicoGreenTM quantification assay (Quant-
iT™ PicoGreen ® dsDNA - Invitrogen). At the pre-determined time-points, 
cell-scaffold constructs and monolayers were washed in PBS solution, then 
incubated in a enzymatic solution, 0.5 mg/ml Proteinase K in PBE overnight 
at 37°C to detach/lyse the cells on the scaffolds. The resulting cell 
suspensions were then collected and mixed with PicoGreen dye at 1:1 
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volume ratio. The mixtures were read using a spectrophotometer for 
fluorescence at 520 nm with excitation wavelength of 485 nm.  
5.3.4 Scanning electron microscopy (SEM) 
Morphological observations were performed with optical microscopy and 
scanning electron microscopy (SEM) (Quanta 200 Scanning Electron 
Microscope – FE – operating mode: low vacuum, gaseous secondary 
electron GSE detector). 
Before imaging, biological samples were fixed by using a glutaraldeyde 
solution (2.5% glutaraldehyde in cacodylic buffer solution, 0.1 M, PH=7.2) 
to preserve the structure of living tissues. Then the samples were dehydrated 
by dipping in a series of aqueous ethanol solutions at increasing 
concentrations. Prior to SEM imaging, samples were sputter coated (Biorad 
SC500, Hemel Hempstead, UK) with a thin layer of gold in argon 
atmosphere (1,4 mA at 5x10-7 for 1 min). 
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5.3.5 Cell staining and confocal laser 
microscopy imaging 
Evaluation of cell attachment and growing on the seeded scaffolds was 
performed by confocal laser microscopy (CLM) (Leica SP%5, Germany) 
after rhodamine phalloidin and DAPI staining according to the 
manufacturers’ protocol (Molecular Probes Inc., Oregon, USA – Product 
codes: R415 and D1306 respectively). Fixation with a formaldehyde 
solution (4% formaldehyde in PBS solution) and permeabilization with 
TritonX (0.2% TritonX in PBS solution) was performed before staining. 
Qualitative cell viability was assessed using fluorescein diacetate–
propidium iodide (FDA–PI) staining, following the manufacturers’ protocol 
(Molecular Probes Inc., Oregon, USA – Product codes: F1303 and 
P1304MP respectively). 
PART 2: fused deposition modelling scaffold for human osteoblasts cell 
cultures 
 
146 
 
5.4 Results and Discussion 
5.4.1 Optical imaging 
Optical microscope imaging were taken at each time point to evidence the 
bridging mechanism used by osteoblasts to grow at the corners of the pores. 
This mechanism is evident when cells reach a certain level of confluence on 
the scaffold surface: in this experiment from day 16 as showed in Figure 5.2 
and Figure 5.3. 
 
Figure 5.2. Optical microscope images of mPCL:TCP scaffolds. The arrow indicates the 
bridging mechanism that cells use to grow in the corner of pores 
100 µm 100 µm 100 µm 
100 µm 100 µm 
Day 2           Day 9        Day 16    
 
 
 
 
 
 
 
 
 
Day 30            Day 45 
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Figure 5.3. Optical microscope images of PDLLA:TCP scaffolds. The arrow indicates the 
bridging mechanism that cells use to grow in the corner of pores 
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5.4.2 Confocal laser imaging: Phalloidin 
rhodamine and Dapi staining 
Cells structure was evidenced by confocal laser microscopy (CLM) after 
Phalloidin rhodamine and Dapi staining.  
In particular Phalloidin rhodamine stained the cell cytoskeleton resulted in 
red fluorescence while Dapi stained the cell nuclei resulted in blue 
fluorescence. 
Both the materials were tested over the predetermined time points. 
Figure 5.4 and Figure 5.6 show the CLM imaging for the mPCL:TCP and 
PDLLA: TCP materials respectively. 
Figure 5.5 and Figure 5.7 illustrate cell morphologies at higher 
magnifications. 
Transmitted images are also reported (smaller images) to better evidence the 
scaffold structure. 
From the images no pronounced differences can be noticed between the two 
materials. 
Cells could spread over the scaffolds uniformly starting from the polymeric 
matrix, and then filling the pores, by a bridging mechanism, starting from 
the corners of the matrix. 
The arrows in Figure 5.4 and Figure 5.6 underline the growth of the cells 
from the corner of the scaffold. 
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45 days  
30 days  16 days  
9 days  2 days  
Figure 5.4. mPCL:TCP (80:20) 
scaffold cell seeded with human 
osteoblasts. Phalloidin Rhodamine 
and Dapi staining at different time 
points. The arrow shows the 
bridging mechanism cells use to 
grow from the corner of the 
structure. The small images are the 
transmitted micrographs 
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2 days  9 days  
16 days  30 days  
45 days  
Figure 5.5. mPCL:TCP (80:20) 
scaffold cell seeded with human 
osteoblasts. Phalloidin Rhodamine 
and Dapi staining at different time 
points. (40x original magnification) 
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9 days  2 days  
45 days  
16 days  30 days  
Figure 5.6. PDLLA:TCP (90:10) 
scaffold cell seeded with human 
osteoblasts. Phalloidin Rhodamine 
and Dapi staining at different time 
points The arrow shows the bridging 
mechanism cells use to grow from 
the corner of the structure. The small 
images are the transmitted 
micrographs 
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2 days  9 days  
16 days  30 days  
45 days  
Figure 5.7. PDLLA:TCP (90:10) 
scaffold cell seeded with human 
osteoblasts. Phalloidin Rhodamine 
and Dapi staining at different time 
points. (40x original 
magnification) 
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5.4.3 Confocal laser imaging: fluorescein 
diacetate–propidium iodide (FDA–PI) 
Osteoblast viability was evaluated by confocal laser microscopy (CLM) 
after fluorescein diacetate-propidium iodide (FDA-PI) staining. In fact, 
FDA stains viable cells green while PI stains necrotic and apoptotic cells 
red. The assay was done according to previously predetermined protocols.  
Osteoblasts seeded over the two FDM scaffold materials were monitored for 
the chosen period of time. Every time point was examined. 
Figure 5.8 and Figure 5.9 show the CLM imaging after staining of 
mPCL:TCP and PDLLA:TCP, respectively. The transmitted images are also 
reported (small images) to better evidence the scaffold structure. 
In both the materials viable cell number increased with time but at day 45 a 
reduction of viable cells was viewed. 
This was most likely due to the high cell density at day 45. 
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Figure 5.8. mPCL:TCP (80:20) scaffold cell seeded with human osteoblasts. fluorescein 
diacetate–propidium iodide (FDA–PI). The small images are the transmitted micrographs 
2 days  9 days  
16 days  30 days  
45 days  
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Figure 5.9. PDLLA:TCP (90:10) scaffold cell seeded with human osteoblasts. fluorescein 
diacetate–propidium iodide (FDA–PI). The small images are the transmitted micrographs 
2 days  9 days  
16 days  30 days  
45 days  
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5.4.4 Scanning Electron Microscopy (SEM) 
Cell adhesion and growth behavior was evidenced by scanning electron 
microscopy (SEM) imaging. 
Figure 5.10 and Figure 5.11 show the SEM imaging for mPCL:TCP (80:20) 
and PDLLA:TCP (90:10), respectively, at the prefixed time points. 
Different magnifications are reported. 
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Figure 5.10. SEM imaging of mPCL:TCP (80:20) scaffold cell seeded with human 
osteoblasts at different time points. The arrow indicates cells bridging mechanism at the 
matrix corners 
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Figure 5.11. SEM imaging of PDLLA:TCP (90:10) scaffold cell seeded with human 
osteoblasts at different time points 
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5.4.5 Proliferation Assay – PicoGreenTM 
To measure the extent of proliferation, cell DNA amount profile was 
calculated, at each time-points by PicoGreenTM quantification assay. 
Figure 5.12 represents the trends of DNA amount profile measured over the 
predetermined time points. DNA amount profile for monolayer cell culture 
is reported as well.  
From the graph it is possible to say that there was an increase of DNA 
amount during the first two weeks. Then a plateau is visible for both the 
materials. 
This trend is expected and confirms the morphological evaluations 
previously showed by CLM and SEM imaging (chapters 5.4.2, 5.4.3 and 
5.4.4). During matrix formation, after day 16, cells don’t grow significantly. 
 
Figure 5.12. DNA amount profile as a function of culturing time 
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6 Conclusions 
Tissue engineering, involving the use of living cells and extracellular 
components from either synthetic and natural polymers, aims to regenerate 
tissues and restore or replace deteriorating or aging biological structures. 
The research work revolves around the use of a novel rapid prototyping 
technique to produce ordered scaffolding supports with a micrometric 
resolution. 
Microfabrication system was developed and used in combination with 
synthetic, PDLA and PLGA, and natural, chitosan, polymeric solutions. 
The reproducibility of the technique was achieved combining together 
proper process parameters and solution viscosities. Material characterization 
tests were used to assess possible material modifications due to the process 
and establish polymer solution viscosity working ranges suitable for 
obtaining well ordered microfabricated scaffolds. 
Thinking at the osteoinductive character of ACP particles the combination 
with chitosan was evaluated to microfabricate scaffolds for bone tissue 
regeneration application. Superficial analyses revealed the effectiveness of 
NaOH treatment to expose the ceramic phase to the biological environment. 
Preliminary biological tests allowed to evaluate cells attachment and 
penetration. In particular different scaffold morphologies with micrometric 
structures were produced and cells behaviour was examined. 
The second part of the work dealt with human osteoblasts cell culture on 
fused deposition modelling scaffolds for bone repair and restoration. This 
rapid prototyping technique makes use of thermoplastic polymers which are 
extruded on a platform; the final 3D scaffolds result to have higher 
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porosities compared to microfabrication; thus oriented toward different 
applications. Cells morphology, viability and proliferation were examined.  
The possibility to have a system able to fabricate reproducible scaffolds 
with a micro-resolution represents a big potential for tissue engineering 
applications. Future microfabrication develops could comprehend the design 
of scaffolds having gradient of porosity, thus varying specifically inside the 
same structure. This could offer a great advantage in those applications 
where porosity is not necessarily constant among the whole structure. 
Furthermore a challenging objective is to develop the microfabrication 
system for organ or tissue printing, a novel concept in which cells and 
hydrogel matrices are spatially organized into layered hybrid constructs, 
with controlled architecture and defined cellular placement. 
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